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ABSTRACT
Activation of tissue-specific genes is a tightly controlled process that nOflally
involves the combined action of several transcription factors and transcriptional co-
regulators. The bone-specific osteoca1cin gene (OC) has been used as a prototype to
study both tissue-specific and hormonal responsiveness. In this study we have examined
the role of Runx2 , VDR and C/EBP factors in the regulation of OC gene transcription.
Contributions of the Runx and VDRE motifs to OC promoter activity were addressed by
introducing point mutations within the context of the rat (- 1 kb) osteoca1cin promoter
fused to a CAT-reporter gene. The functional significance of these mutations was
assayed following transient transfection and after genomic integration in ROS 17/2.
osteoblastic cell lines. Furthermore , we tested the effect of these mutations on the
chromatin organization of the OC promoter. Our data show that all three Runx sites are
required for maximal activation of the OC promoter and that the distal sites contribute
significantly to the basal activity. Strikingly, mutation of the three Runx sites abrogates
responsiveness ofthe OC promoter to vitamin D; this loss is also observed when only the
Runx sites flanking the VDRE are mutated. Chromatin changes that result in the
appearance of DNase I hypersensitive sites during activation ofthe OC gene are well
documented. Mutation of the three Runx sites results in altered chromatin structure as
reflected by absence of DNase I hypersensitive sites at the vitamin D response element
and over the proximal , tissue-specific basal promoter. These data are consistent with the
critical role of Runx2 in osteoblast maturation and bone development.
Mutation ofthe VDRE resulted in a complete loss of vitamin D responsiveness;
however, this mut t promoter exhibited increased basal activity. The two DNase I
III
hypersensitive sites characteristic of the transcriptionally active DC gene in osteoblastics
cells were not altered upon mutation of the VDRE element, although restriction enze
accessibility in the proximal promoter region was decreased. We also found an increased
level of histone H3 acetylation at the VDRE mutant promoter in comparison to the
endogenous gene. Thus binding ofVDR to DC promoter is required to achieve a normal
transcriptional regulation and chromatin structure of the DC gene.
Although Runx2 is considered a master gene for bone development and osteoblast
differentiation, it is noteworthy that osteoblast-specific transcription of the rat 
promoter occurs even in the absence of Runx sites. Therefore , other transcription
factor(s) should be able to drive DC expression. We characterized a C/EBP enhancer
element in the proximal promoter of the rat osteoca1cin gene that resides in close
proximity to a Runx element, essential for tissue-specific activation. We find that
C/EBP or () and Runx2 factors interact together in a synergistic manner to enhance 
transcription in cell culture systems. Mutational analysis demonstrated that this
synergism is mediated through the C/EBP responsive element in the DC promoter and
requires a direct interaction between Run2 and C/EBP or ().
Taken together, our findings strongly support a mechanism in which
combinatorial interaction of Runx2 , VDR, C/EBP or () and probably other transcription
factors are needed for regulating DC expression. In this process Runx factors not only
act as simple transcriptional transactivators but also by facilitating modifications in
promoter architecture and maintaining an active conformation of the target gene
promoter.
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I. BONE BIOLOGY
1. Bone Tissue
Bone is a dynamic connective tissue that not only provides protection from
external injury to the brain and spinal cord , but also houses the bone marrow , supports
hematopoiesis , provides an ample source of calcium and phosphate and is essential for
the respiratory process.
There are three major divisions of the vertebrate skeleton: craniofacial , axial
and appendicular and each one of them is derived from distinct embryonic origins. The
neural crest gives rise to the craniofacial skeleton, the scJerotome forms most of the
axial skeleton , and the lateral plate mesoderm generates the appendicular skeleton. In
regions of the craniofacial skeleton and the c1avicJe, differentiation into osteoblasts
produces bone directly by a process known as intramembranous bone formation. In the
remaining skeleton , differentiation into chondrocytes produces a framework of carilage
models (anlagen) of the future bones; these carilage models are subsequently replaced
by bone by the process of endochondral ossification (MundI os and Olsen , 1997).
During skeletogenesis, four primary phases can be distinguished: (1) the
migration of precursors cells to the location in the embryo where skeletal elements wil
develop, (2) the epithelial-mesenchymal interaction that leads to (3) characteristic
mesenchymal condensations of high cell density and (4) the differentiation into
osteoblasts or chondrocytes (Hall and Miyake, 2000).
Progressing from condensation to differentiation of cells identifiable as
chondroblasts or osteoblasts requires dov.n-regulation of genes controllng proliferation
and up-regulation of genes associated with differentiation. The patterns and molecular
regulatio of mesenchymal cell differentiation are only superficially known. Cells that
paricipate in bone formation originate from pluripotent mesenchymal stem cells that
can differentiate to other phenotypes like myoblasts , adipocytes and fibroblasts (Fig.
1). Commtment of the mesenchymal stem cell to the different cell lineages is
believed to be determined by transcription factors that act as "master switches
inducing the expression of a set of specific genes that characterize the muscle
adipocyte , chondrocyte or osteoblast cell (Fig. 1. 1).
In addition to osteoblasts (the bone forming cells), and chondroblasts (the
carilage forming cells), there is a third specific cell type of the skeleton: the osteoclast
or bone-resorbing cell. Osteoclasts are derived from the hematopoietic stem cells , and
have a common differentiation pathway with the monocyte/macrophage lineage until
the final differentiation steps. Osteoclast progenitors are recruited to bone via blood
circulation. The activity and differentiation of osteoblasts and osteoclasts are closely
coordinated during embryonic development of the bone and during growth and adult
life as bone undergoes continuous remodeling.
2. The Osteoblast Phenotype
A) In Vivo Differentiation Of Osteoblasts
Based on morphological and histological studies, osteoblastic cells are
categorized in a presumed linear sequence progressing from osteoprogenitor to lining
cells or osteocytes. The progression of osteoblast maturation requires the sequential
activation and suppression of genes that encode phenotypic and regulatory proteins.
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Figure 1.1 Cell lineages: Pluripotent mesenchymal stem cell can differentiate to
originte different cell lineages triggered by the expression of "master genes
(Adapted from Borfmen H. and Czerniak B. "Molecular Biology of Bone
Tumors" in Bone Tumors , 1998).
Signaling molecules like Bone-Morphogenetic Proteins (BMPs) and Transformng
Growth Factors (TGFs) indirectly mediate a cascade of gene expression. Transcription
factors and regulatory proteins that directly engage in protein-DNA and in protein-
protein interactions are also important for the development of bone tissue and
osteoblast differentiation (Fig. 1.2). The molecular and cellular processes involve in
the transformation of the most primitive pluripotent cell to the undifferentiated
multipotential cell and presumed osteoprogenitor are not understood. The stem cells
that give rise to progeny for bone formation and tissue renewal can be identified only
by biologic consequences.
The osteoprogenitor appears to have limited cell renewal capacity compared to
the stem cell. The determined osteoprogenitor is recognizable in bone as a
preosteoblast , a key feature of the preosteoblast population is its capacity to divide and
increase the size of bone. Preosteoblasts are usually observed as one or two layers of
cells behind the osteoblast near bone-forming surfaces; i. , they are usually present
where active mature osteoblasts are laying down a bone matrix (Fig. 1.3). These cells
appear elongated , fibroblastic , or spindle shaped with an oval or elongated nucleus and
with notable glycogen content. Preosteoblasts may express a few phenotypic markers
of the osteoblast, e. , alkaline phosphatase , but less than the mature osteoblast. Once
the preosteoblast ceases to proliferate it wil differentiate into a mature osteoblast. 
vivo, several structural features characterize this osteoblast, including its size and
cuboidal morphology, a distinguishing round nucleus, a strongly basophilic cytoplasm
and a prominent Golgi complex. The osteoblast synthesizes and vectorially secretes
most of the proteins that form the bone extracellular matrix (ECM). As the mature
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osteoblast becomes surrounded by the mineralized matrix , the cell differentiates
further into an osteocyte , which is considered the most mature or terminally
differentiated cell of the osteoblast lineage.
B) In Vitro Differentiation Of Osteoblasts
A large number of cell culture models are currently available to study the
expression of osteoblast-related genes 
in vitro. These include primary culture from
calvaria or trabecular bone from several mammalian species , osteosarcoma-derived cell
lines, and experimentally immortalized cells. Some of these in vitro models, especially
the calvaria-derived cultures, undergo changes that mimic osteoblastic differentiation 
vivo (Rodan and N oda, 1991).
Primar cultures of calvarial-derived rat osteoblasts develop a mineralized extra
cellular matrix with a bone tissue-like organization. A temporal pattern of gene
expression reflecting progressive differentiation of the osteoblast has been mapped
from the proliferating cell to the fully mature osteocyte in vitro (Bellows et aI. , 1986;
Owen et aI., 1990a). The general profie of cell growth and bone phenotypic gene
expression characterizes three major periods of cell and tissue development:
proliferation , matrix maturation and mineralization (Fig. 1.4). Genes supporting cell
cycle progression (e. , histones), cell growth control (e. , c- fos , c-jun) and ECM
biosynthesis (e.g, collagen, fibronectin , TGF ) are expressed during the initial
proliferation period. At the first key transition point, genes associated with the
proliferation process are down regulated while genes related to maturation and
organization of the bone ECM are induced (e.g., alkaline phosphatase , matrix Gla
protein). At a second transition point, expression of genes associated with ECM
Prol iferation
Day6
Matrix Maturation
Day 12
Mineralization
Day 20
Day
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Figure 1.4 In vitro developmental stages of rat osteoblasts: Top panel: Fetal calvarial
derived rat primary osteoblast cultures were grown for the indicated days and stained with
toluidine blue to show actively proliferating cells (d6). Matrix maturation shows the alkaline
phosphatase histochemistry indicating a post proliferative osteoblast culture with every cell
stained positively forthe enzyme. Mineralization of bone-like nodules is demonstrated by the
von Kossa silver and alakaline phosphatase double stain. The large black masses indicate the
mineral deposition and failure of red staining demonstrates the absence of alkaline
phosphatase enzyme. Bottom panel shows Northern blot analysis of the temporal expression
of osteoblast phenotype related genes during development of the osteoblast phenotype.
Cessation of proliferation (day 1-6) leads to induction of phenotypic markers that characterize
the subsequent postproliferative stages. The second stage (matrix maturation) is characterized
by maximal levels of alkaline phophatase, considered an early marker of the differentiated
osteoblast. The maturation of osteoblast development (mineralization) is achieved
concomitant with maximal levels of OC expression
mineralization are upregulated (e.g., osteocalcin and osteopontin), as well as
genes associated with the establishment and maintenance of the fully differentiated
bone cell (e.g., collagenase).
3. The Osteocalcin Gene
Osteocalcin (OC) is a major noncollagen 1J protein product of the
differentiated osteoblast, which forms the ECM. The protein is synthesized in a pre-pro
form of 10 kDa; but it is secreted as a 5.6 kDa protein that accumulates in the bone
ECM bound to mineral. It contains three residues of a calcium binding amino acid y-
carboxy glutamic acid (Gla), that are formed after protein translation by carboxylation
of glutamic acid residues by a vitamin K and C02 dependent carboxylase enzyme
complex. In the presence of calcium, the Gla residues allow specific conformational
changes and promote osteocalcin binding to hydroxyapatite and subsequent
accumulation in bone matrix (Hauschka et al. , 1989).
The physiological role of osteocalcin is still unknown. It has been proposed that
osteocalcin may act as inhibitor of hydroxyapatite deposition (Boskey et aI. , 1985) or it
may have a role in mediating bone resorption (Lian et aI. , 1986; Glowacki and Lian
1987; Lian et aI. , 1984). Defective osteocalcin production has been observed in some
humans and animals with osteopetrosis, a severely deforming disease characterized by
the failure to remodel bone and calcified cartilage (Lian and Marks, 1990; Shalhoub et
aI. , 1994; Bollerslev et aI. , 1994).
Both the human and the rat osteocalcin genes exhibit similar overall
organization. The human gene is a single copy gene localized on chromosome 
(Puchacz et aI. , 1 9). It has a size of - 1.2 kb with four exons that predict a protein of
125 amino acids, the signal peptide contains 26 amino acids in exon 1 , a propeptide of
49 amino acids in ex on 2 along with the y-carboxylation recognition sequence , two
stretches that become carboxylated in exon 3 , and the remainder of the molecule and
untranslated region in exon 4. Interestingly, in selected strains of rats and in mouse
three osteoca1cin related genes have been found, two of which (OG 1 and OG2) are
activated in bone and one (osteoca1cin related gene ORG) in kidney (Desbois et aI.
1994; Rahman et aI. , 1993). Osteocalcin deficient mice are normal at birth, viable
fertile, have no skeleton patterning defects and no ectopic bone formation. The
expression of noncollagenous proteins such as osteopontin (OP), matrix gla protein
(MGP) and bone sialoprotein (BSP) is not significantly affected by the absence of
osteoca1cin. Over time the mutant mice develop a phenotype marked by higher bone
mass and bones of improved functional quality (Ducy et aI. , 1996).
Extensive screening of protein and mRA extracts (Fraser and Price, 1988) and
of tissue sections by immunohistochemistry (Bronckers et aI. , 1985; Camarda et aI.
1987) from virtually all tissues has failed to detect osteoca1cin in any tissue other than
bone and dentin. Consequently, osteoca1cin has been extensively used both as a marker
of osteoblast differentiation and to study tissue-specific gene expression. Identification
of promoter regulatory elements (Fig. 1.5) that are responsive to basal and tissue
specific transactivation factors , steroid hormones, and other physiologic signals
provides a basis for our understanding of regulatory mechanisms contributing to tissue-
specificity, developmental expression and biological activity of osteoca1cin (Lian et aI.
1999b; Lian et aI. , 1998).
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The promoter of the rat osteocalcin gene has a modular organization consisting
of positive and negative regulatory elements with consensus sequences for numerous
physiologi modulators that have been shown to affect synthesis of OC in vitro. These
include vitamin D (Bortell et aI. , 1992; Markose et aI. , 1990; Kerner et aI., 1989;
Demay et aI., 1990; Morrison et aI., 1989; Lian et aI. , 1989b), estrogen, glucocorticoids
retinoic acid, TGF , cyclic nucleotides and y-interferon. A series of elements
contributing to basal and tissue specific expression include a TAT A sequence (located
at -42 to -39), and binding elements for AP- , OC box for homedomain protein
binding (Dlx5 , Msx2 and CDP/cut helix-loop-helix proteins) and an osteoblast specific
complex (Hoffmann et aI. , 1994; Tamura and Noda, 1994; Towler et al. , 1994a).
Interestingly, the minimal OC promoter containing the OC box is suffcient to support
osteoblast-specific expression in vitro (Heinrichs et aI. , 1993).
In the characterization of bone-specific transcription factor complexes
associated with the rat osteocalcin gene sequences, three Runx regulatory elements
were identified and designated as sites A, Band C (Banerjee et aI. , 1996a; Merriman et
aI. , 1995; Bidwell et aI., 1993). Site C (- 135 to - 130) resides in the proximal promoter
and sites A and B (-604 to -599 and -440 to -435), which flank the vitamin D response
element (VDRE -461 to -445), are located in the distal region.
Osteocalcin is the best studied example of a bone-specific and vitamin D
responsive protein. The vitamin D responsive element (VDRE) discovered in the
osteocalcin gene promoter (Morrison et aI. , 1989; Markose et aI. , 1990; Lian et aI.
1999b; Sone et aI. , 1991) represents the key component of steroid mediated
transcriptional enhancement. It has been shown that ligand-dependent binding of the
vitamin D receptor in intact cells is directly correlated with transcriptional up-
regulatio (Breen et aI. , 1994; Demay et aI., 1990; Terpening et aI., 1991; Lian et aI.,
1989b). However, vitamin D is unable to induce osteoca1cin gene expression prior to
its basal expression during the osteoblast differentiation sequence (Owen et aI. , 1991;
Owen et aI., 1993; Shalhoub et aI., 1992).
II. BONE RELATED TRANSCRIPTION FACTORS
1. Runx Proteins
Runt related factors (Run x) belong to the Runt domain gene family. 
Drosophila melanogaster the pair rule gene runt plays an important role in the
formation of the segmented body pattern, in sex determination and in the development
of the nervous system (Canon and Banerjee, 2000). The a subunit of these
heterodimeric transcription factors binds to DNA weakly by recognizing the sequence
PuffACCPuCA (Meyers et aI. , 1993; Kamachi et aI. , 1990). There are three
mammalian genes which encode the a subunit: RUNX1 (CBFA2/ PEBP2aB/A.l\L1),
RUNX2 (CBFA1/ PEBP2aAJAML3) and RUNX3 (CBFA3/PEBP2aC/AML2). The 
subunit, called Cbf\/Pebp2b, does not directly interact with DNA, but associates with
the a subunit and increases the affnity of the a subunit to DNA. Multiple isoforms for
each mammalian gene product exist , which are generated by alternative splicing;
however, all the Runx proteins share a functional domain, referred to as the runt
homology domain (RHD) because it is 70% identical to a region in the Drosophila
protein Runt (Fig. 1.6). The three mammalian Runx proteins are more than 50%
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Figure 1.6 Nomenclature and structural comparison of Runx proteins:
Schematic comparison of a transcriptionally active protein isoform from each of the
mammalian RUNX genes and the Drosophila runt gene. The C- terminus penta-
peptide (VWRPY) is 100% conserved. Amino acid numbers for the full- length
proteins and of various regions are indicated below. The presence of two unique
domain in the amino andc:arboxy regions of the Runx2 protein is shown with their
respective amino acid numbers. Different nomenclatures used tor runt domain
proteins are shown in the table. The nomenclature committee of the Human Genome
Organization has recently adopted the RUNX designation for the runt related
transcription factors.
identical at the amino-acid level , and greater than 93% identical within the RHD , which
is responsible for the DNA binding activity and CbfJ interaction.
Mice with null mutation of Runx 1 are embryonic lethal at midgestation due to
hemorrhage in the central nervous system and disruption of fetal liver hematopoiesis
(Okuda et aI. , 1996). A similar phenotype was found in the homozygous mutant mice
for CBFb/PEBP2b (Wang et aI. , 1996). Runx2 nullizygous mice present a complete
absence of bone, smaller size and neonatal death due possibly to respiratory failure
(Komori et aI. , 1997; Otto et aI., 1997). Runx 3 knock out mice are born in mendelian
ratios; however they display hyperplasia of the gastric epithelium and die within 24 h of
birth due to low glucose levels in the blood stream (Li et aI. , 2002).
Runx proteins can act as activators or repressors of transcription. In their
capacities as transcriptional activators , the mammalian Runx proteins interact with
several other transcriptional regulatory proteins e. : p300, Androgen Receptor (AR),
Glucocorticoid Receptor (GR), PD. 1 , Smad 1 , Hairy and Enhancer of Split 
homologue (HES- l) (Kitabayashi et aI. , 1998; Ning and Robins, 1999). As repressors
Runx proteins can interact with the GrouchoffLE class of co-repressors through a
conserved VWRPY C-termnal sequence motif (Levanon et aI., 1998), or can
alternatively repress transcription by a Groucho-independent mechanism (Javed et aI.,
2000; Javedet aI. , 2001). The current interpretation of numerous studies is that Runx
proteins function as context dependent regulators, which activate or repress
transcription depending upon the organization of a paricular promoter/enhancer in a
specific cell type at a certain time.
1"-,,,
An interesting property of Runx proteins is their association with the nuclear
matrix, an anastomosing network of fibers and fiaments first identified by Berezney
and Coffey (Berezney and Coffey, 1975). In fact , a conserved 31-35 aminoacid
intranuclear targeting signal in the C-terminus of Runx 1 , 2 and 3 has been identified
(Zeng et aI. , 1997; Zaidi et aI., 2001). Association of Runx factors with the nuclear
matrix increases their transactivation potential for various promoters (Zeng et aI.
1998).
2. Vitamin D And Vitamin D Receptor
The active form of vitamin D, 1 25-(OH)2 D3, exerts its effects by binding to the
vitamin D receptor (VDR), which is a member of the nuclear receptor superfamily. 
VDR is a phosphoprotein that undergoes a hormone-dependent phosphorylation in
intact cells (Pike and Sleator, 1985). Phosphorylation of VDR by protein kinase A
(PKA) results in a reduction in the transactivation capacity of the receptor in response
to vitamin D (Jurutka et aI. , 1993). In vivo over-expression of casein kinaseJI, which
phosphorylates VDR at Ser 208 in response to vitamin D treatment, causes an increase
in 1 25(OHhD induced transcriptional activity (Jurutka et aI. , 1996). Phosphorylation
of Ser 51 by protein kinase C diminishes VDR binding and nuclear localization of the
VDR (Hsieh et aI. , 1991; Hsieh et aI. ); this evidence ,strongly suggests that differential
phosphorylation plays a role in determining VDR activity.
Binding of the ligand to VDR triggers a cascade of events, resulting in the
transcriptional regulation , activation or suppression , of specific target genes (Fig. 1.7).
A key event is the ligand-induced change in receptor conformation (Allan et aI. , 1992;
van den Bemd et aI. , 96 A.D. ) that exposes sites for interaction with specific cofactors.
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Figure 1.7 Proposed mechanim of action of 1 25(OH) in target cell: The
free form of vitamin D (D ) enters the target cell and interacts with the vitamin D
receptor (VDR), which is phosphorylated (P). The ligand- VDR complex interacts
with the retinoid acid X receptor (RXR) to form a heterodimer, which wil bind to
the vitami D responsive eleIrnt (VDRE), causing an enhanceIrnt or inhibition of
transcription of vitami D responsive genes. (Taken from Holick MF "Vitami D:
Photobiology, Metabolism, Mechanism of Action, and Clinical Applications" in
Favus MJ Primer on the Metabolic Bone Diseases and Disorders of Mineral
Metabolism" Fourh Edition, 1999)
In addition to heterodimerizing with the retinoid X receptor (RXR), VDR has been
shown to interact with SRC- , a member of the p160 class of co-modulators that
possesses intrinsic HAT activity. VDR also interact with THIB (a protein associated
with the basal transcription machinery), NCoA 62 (nuclear receptor coactivator, 62 000
Da), DRIPs (vitamin D-receptor-interacting proteins) and Smad 3 (a member of the
Smad protein family of intracellular transducers of the TGF p-BMP superfamily). The
paricular co-regulatory proteins recruited to VDR may contribute to the specificity of
transcriptional regulation.
For several VDR target genes a functional VDRE has been defined. Generally
it consists of two imperfect direct repeats of a hexameric nucleotide sequence spaced by
three base pairs (DR3-type VDRE), and although the consensus sequence AGGTCA is
stil recognizable, considerable heterogeneity in half-site sequences exists. This
heterogeneity is the basis for positive and negative VDREs (Van Leeuwen et aI., 2001).
In most cases the proximal (3' ) half-site is the binding site for the VDR; whereas the
distal site (5' ) half site is the binding site for its dimer partner RXR (Staal et aI., 1996;
Jin and Pike , 1996; Lemon and Freedman , 1996). Besides the DR3-type VDREs, DR4-
type VDREs and inverted palindromics motifs spaced by nine nucleotides (IP9) have
been characterized as functional VDREs. Furthermore, VDR binding to direct repeats
with a spacing of six nucleotides , a palindrome without spacing and an inverted
palindrome with a 12 nucleotides spacing has been reported (Carlberg et aI. , 1993).
The VDR knock out mice present hypocalcaemia, hypophosphatemia,
hyperparathyroidism and severely impaired bone formation (Li et aI. , 1997). A recent
study using mice transgenic for VDR under control of the osteocalcin promoter
indicated bone anabolic effects of vitamin D. In mice expressing the transgene , a 20%
increased trabecular bone volume, increased bone strength and reduced bone resorption
surface was observed (Thomas et aI. , 2000).
3. C/EBP Transcription Factors
The CCAAT/ enhancer-binding proteins (C/EBPs) comprise afamily of
transcription factors that are critical for normal cellular differentiation and function in a ,
variety of tissues. There are currently six known members of the C/EBP family
designated as C/EBPa, , 0, y, E and S (Cao et aI., 1991). C/EBP, like many
transcription factors, is a modular protein , consisting of an activation domain , a DNA
binding basic region and a leucine-rich homo and/or hetrodimerization domain (Agre et
aI. , 1989; Vinson et aI. , 1993). C/EBP dimerization is a prerequisite to DNA binding
(Birkenmeier et aI. , 1989).
, C/EBPa was the first member cloned (Landschulz et aI. , 1988) (Birkenmeier et
aI. , 1989). There are two isoforms of this protein that are generated from the same
mRNA by a ribosomal scanning mechanism (Descombes and Schibler, 1991).
, Targeted disruption of C/EBPa results in perinatal lethality due to hypoglycemia
(Wang et aI. , 1995).
C/EBP is constitutively expressed at high levels in liver, intestine, lung and
adipose tissues (Cao et al., 1991). C/EBP , like the a family member, has two
isoforms generated by ribosomal scanning. The truncated protein translated from the
third AUGexhibits a dominant negative mechanism of transcriptional regulation
(Descombes and Schibler, 1991). Protein kinase-dependent phosphorylation of
C/EBP appears to activate transcription (Trautwein et aI.; 1993). C/EBP knockout
mice show severe defects in carbohydrate metabolism, lipid storage, macrophage
maturation and female sterility (Tanaka et aI. , 1995).
C/EBPyand 3 are both intronless genes which are expressed constitutively.
C/EBPy is highly expressed in non-differentiated progenitor cells (Roman et aI. , 1990),
whereas C/EBP3 is detected in intestine , adipose tissue and lung and is highly
stimulated by Lipopolysacaharide (LPS) (Alam et aI. , 1992; Cao et aI. , 1991). C/EBPy
is missing the N-terminus trans activating element but can heterodimerize with C/EBPa
and , thereby interfering with transcriptional regulation of target genes by these
proteins (Cooper et aI. , 1995). In contrast the ability of C/EBP3 to transactivate target
genes is comparable to C/EBPa and (Cao et aI. , 1991). Homozygous disruption of
C/EBP3 shows neurologic and lipid storage defects. Mice deficient for both C/EBP
and C/EBP3 expire perinatallyand lack lipid accumulation in brown adipose tissues
(Tanaka et aI. , 1997).
C/EBPE is represented by four isoforms, arising from alternative promoters
and/or splicing (Yamanaka et aI. , 1997). C/EBPE promotes granulocytic differentiation
of the promyelocytic cell line NB4 and its expression can be induced by retinoids
(Morosetti et aI. , 1997). C/EBPE null mice die within a few months after birth due to
immature granulocyte and myeloid proliferation (Yamanaka et aI., 1997).
C/EBPS is ubiquitouslyexpressed and is induced by DNA damage (Fornace, Jr,
et al. , 1989). The presence of two prolines in the DNA binding domain of C/EBPS
results in an altered conformation and consequently the heterodimers are unableto
interact with the C/EBP motifs (Ron and Habener, 1992).
C/EBP proteins are known to interact both physically and functionally with
other transcriptional activators or co-activators such as NF- , Stat3 and PPARy. Both
C/EBP and Runx factors have been shown to cooperate with chromatin remodeling
factors (p300, SWI/SNF) and other enhancer-binding proteins (Kitabayashi et aI. , 1998;
Kowenz-Leutz and Leutz, 1999) and RunxllAML- l (Steinet aI. , 1993; Zhang et aI.
1996a).
III. CHROMA TIN STRUCTURE AND TRANSCRIPTION
lit
The ability of each cell to program its genome and determine which genes are to
be expressed at a given time and under certain stimuli is central to tiss e differentiation.
A fundamental mechanism controlling the selectivity of gene expression is the limited
ability of many transcription factors to access the genome. This is achieved by
packaging genes into chromatin , which greatly impairs the binding of many proteins to
their target DNA sequences.
The basic unit of chromatin, the nucleosome , consists of 146 base pairs of DNA
wrapped around two subunits each of the highly conserved core histones H2A, H2B,
H3 and H4 (Kornberg, 1974; Luger et aI. , 1997). In addition , the linker histone HI
binds nucleosomes, facilitating chromosome condensation and serving regulatory
functions (Crane-Robinson , 1999; Bouvet et aI. , 1994). Nucleosomes assemble into
increasingly condensed structures termed the lOnm nucleosomal fiament, the 30nm
fiber, and ultimately chromosomes (Fig. 1.8).
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Figure 1.8 Levels of Chromatin Packing: DNA associates with a histone octaIrr to
form the nucleosoIr (beads on string). Each nucleosome associates with histone HI , and
the fier coils into a solenoid structure (30-nm fiber). In interphase chrOImsomes, long
stretches of 30-nm chromatin loop out from extended scaffolds. In Irtaphase
chromosomes, the scaffold is folded into a helix and further packed into a highly
compacted structure. (Taken from Alberts , Bray, Johnson, Lewis, Raff, Roberts, Walter
http://www.essentia1cellbiology.com)
NET RESULT: EACH DNA MOLECULE HAS BEEN
PACKAGED INTO A MITOTIC CHROMOSOME THAT
IS 50.00x SHORTER THAN ITS EXTENDED LENGTH
Early studies of gene regulation in eukaryotes identified activator proteins
(transcriptio factors) that bind to short DNA motifs found in the promoter and
enhancer regions of genes. The regulatory sequences of most eukaryotic genes contain
binding sites for multiple transcription factors , allowing each gene to respond to
multiple signaling pathways and facilitating the fine-tuning of transcript levels. The
activities of many transcription factors are context dependent and can be modulated by
other regulators bound nearby. It was first thought that eukaryotic activators , like the
corresponding proteins of prokaryotic cells , exert their effects directly, through contacts
with components of the transcription machinery. Then genetic and biochemical studies
in yeast revealed the existence of global transcription regulators that go between
activators (or repressors) and the transcription machinery (Bjorklund et al. , 1999).
Two broad classes of global regulators can be distinguished, those that affect the
chromatin template and those that function through RNA polymerase and associated
proteins. Members of the first class include SWI/SNF and ISWI chromatin-remodeling
complexes, histone acetyltransferase (HAT) complexes , and histone deacetylase
(HDAC) complexes. The second class is represented by the Mediator complex in yeast
and by one or several closely related complexes in mammalian cells (DiRenzo et aI.
2000; Rachez and Freedman , 2001). It is generally believed that these regulators
function in distinct stages , with alteration of the chromatin template preceding the
stimulation of RNA polymerase activity.
Co-regulators that act on chromatin can be divided into two general subgroups:
ATP-dependent nucleosome remodeling complexes and activities that catalyze post-
translational modifications of histones. While both A TP-dependent remodeling and
histone modifying complexes can bind nonspecifically to DNA, several independent
observations imply that the activities of these complexes are regulated both spatially
and temporally. For example, human SWI/SNF paricipates in nuclear receptor-
mediated transcriptional regulation , and both the glucocorticoid receptor and the
estrogen receptor have been shown to recruit SWI/SNF to responsive promoters (Deroo
and Archer, 2001; Hassan et aI. , 2001). Nuclear HAT complexes and transcription
coactivators with intrinsic HAT activities have also been found to interact with
transcriptional activators (Roth et aI., 2001). Direct interactions between activators and
these complexes can have three functional consequences that may affect the overall rate
of chromatin remodeling: First , these interactions can specifically increase the affnity
of the remodeling complex for a given DNA region due to the contacts between the
activator and the complex resulting in an increased local concentration of the
remodeling factor. Second , assuming that the binding of the remodeling complex to the
chromatin is the rate-limiting event , targeting would increase the rate at which the
remodeling complex binds to chromatin. Finally, it is possible that interaction of the
remodeling complex with the specific binding factor may directly affect the remodeling
activity.
Alterations in the chromatin organization of the osteoca1cin gene promoter
during, osteoblast differentiation provide a paradigm for remodeling chromatin structure
and nucleosome organization that is linked to phenotype-specific gene expression.
Basal expression and vitamin D enhancement of OC are accompanied by increased
accessibility to DNase I. In proliferating osteoblasts, where OC is not being expressed
the promoter of the gene is uniformly packed in nucleosomes. This nucleosomal aray
on the OC promoter contributes to maintaining the repression of gene transcription
(Fig. 1.9). As osteoblast development progresses andOC expression stars , two DNase
I hypersensitive (DHS) regions are formed encompassing the VDRE and the Runx
sequences in the proximal and distal promoter (Fig. 1.9). Moreover, vitamin D up'-
regulation of OCexpression results in an increased hypersensitivity in both DHS
regions (Montecino et aI., 1994b). These changes in nuclease accessibility are
accompanied by changes in nucleosome placement (Montecino et aI. , 1994a); in fact
when the gene is being actively transcribed the proximal region and upstream steroid
hormone responsive enhancer sequence appear to become nucleosome free, allowing an 11\t;
111
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1!l1
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increased accessibility to transcription factors. The same pattern of nuclease
accessibility is observed in established cell lines. Osteoblastic cell lines that express
OC and that are responsive to vitamin D (e. , ROS 17/2.8) exhibit the two DHSin the
OC promoter; meanwhile in osteoblastic cell lines that do not express OC (e. , ROS
24/1), the OC promoter region is resistant to DNase I digestion (Montecino etaI.
1996b).
Activation of tissue-specific genes is a tightly controlled process that normally
involves the combined action of several transcription factors and transcriptional co-
regulators (Graves, 1998; Thanos and Maniatis , 1995; Maniatis et aI. , 1998). Runx2 is
essential for osteoblast differentiation and regulates the expression of numerous bone-
related genes. VDR belongs to the steroid and thyroid hormone receptor superfamily
and mediates the biological effects of vitamin D, a physiologic regulator of bone
formation. Runx2 , and VDR factors have been shown to cooperate with chromatin
remodeling factors (p300, SWI/SNF) and other enhancer-binding proteins (Kitabayashi
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Figure 1.9 Chromatin modifications at the Osteocalcin locus during osteoblast
development influence OC transcription: During in vitro differentiation of primary
rat calvarial cells the activation of DC expression is noted only in mature osteoblasts.
No DNaseI hypersensitivity is detected when the gene is silent (dO-dl 0) indicating a
close conformation of the chromatin. Concomitant with DC activation in post-
proliferative , alkaline phosphatase positive mature osteoblast the appearance of the
two DNaseI hypersensitive sites are evident. Vitamin D treatment results in increased
DC transcription which is accompanied by enhanced nuclease accessibility.
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et aI. , 1998; Kamei et aI. , 1996). Transcription of the rat and human OC genes
is strongly influenced by 1,25-dihydroxyvitamin D. The rat OC promoter contains
three recognition motifs for Runx interaction (Sites A, B and C), as well as a vitamin D
responsive element (VDRE). Because both Runx and VDR can recruit other
transcription factors and cofactors into regulatory complexes (Aronson et aI., 1997;
Kitabayashi et aI. , 1998b; Lemon and Freedman, 1999) (Rachez et aI. , 1999), and VDR
can also interact with the basal transcription machinery (MacDonald et aI. , 1995a;
Blanco etaI. , 1995; Lemon et aI. , 1997), their binding sites may impose structural
constraints on the OC promoter to facilitate interactions and activities of the proximal
and distal elements. Our working hypothesis is that Runx2 and VDR factors are
required not only to regulate the transcription of OC but also for the chromatin
remodeling events that accompany OC gene expression. We addressed this by
introducing into the OC promoter point mutations that abolish binding of Runx or VDR
and generating a series of osteoblastic ROS 17/2.8 stable cell lines with integrated wild
type or mutant promoters. The effects of these mutations on transcriptional activity and
chromatin organization of the OC promoter were analyzed. Our results establish an
essential role for Runx2 not only in transcriptional regulation but also in hormonal
responsiveness and in the chromatin re-arrangements required for maximal OC
expression (Chapter 3).
The data presented in Chapter 4 support the requirement of the VDRE for both
basal and vitamin D enhancement of OC transcription. Mutational analysis indicates
that chromatin changes in the OC promoter upon hormone treatment require an intact
VDRE.
Although Runx2 is considered a master gene for bone development and
osteoblast differentiation, it is noteworthy that osteoblast-specific transcription of OC
occurs even in the absence of Runx sites in the rat OC promoter (Javed et aI. , 1999;
Hoffmann et aI. , 1996). Therefore , transcription factor(s) other than Runx2 may drive
DC expression. In this regard, the role of C/EBP transcription factors in regulation of
the DC promoter activity is presented in Chapter 5. C/EBP is a family of transcription
factors that are critical for normal cellular differentiation and metabolic functions in a
varety of tissues. Our studies demonstrate that C/EBP factors are potent activators of
OC expression. We observed functional synergism between C/EBP and Runx2 that'
may account for the maximal induction of the OC gene in mature osteoblasts.
Consistent with this role peak expression of Runx2 , C/EBP and 8 occurs concomitant
with maximal levels of OC in differentiated osteoblasts.
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MA TERIAL AND METHODS
Site Directed Mutagenesis And Expression Constructs
Constructs containing the rat OC (- 097/+23 or -208/+23) promoter fused to
the chloramphenicol acetyl transferase (CAT) gene have been described previously
(Banerjee et aI. , 1996b). Site directed mutagenesis was performed to incorporate two-
nucleotide substitutions into the core-binding motif (ACC) of each individual Runx site
(RACCRCW) in the 1.1 kb rat osteocalcin (OC) promoter fragment (Fig. 3. 1).
Mutations were generated by a PCR based approach (Ausubel et aI. , 1997) using the
Ibi
fol1owing synthetic oligonucleotides (Integrated DNA Technologies, Inc. , Coralvile
I!I
I!t
IA): Site A: 5' CCATCAAAAa ACTAAATAAGAAATGCC 3'; Site B: 5'
CATTACTGAttGCTCCTTCCTGGGG 3'; Site C: 5'
f!!GTCACCAA aACAGCATCCTTTG 3' and pUC/M13 Reverse primer:
TCACACAGGAAACAGCTATGAC3'
. The mutations (indicated by lower case
letters) were selected such that no other DNA-protein binding sites would be generated.
Plasmids bearing mutations in two of the three Runx sites were generated by replacing
the wild type sequence with the mutant by restriction digestion of the - 1 kb rOC
promoter. The mABC plasmid bearing mutations in al1 three Runx sites was obtained
by digestion of mAB with Bgl II-Hind III to release the wild type site C , which was
replaced with the mutant site C plasmid fragment.
The same approach was used to generate the -208 OC-CA T C/EBPm plasmid
containing mutation of the C/EBP binding site in the -208 OC promoter (shown in
lower case), in this case the oligonucleotides used were:
GGTTTGACCTAgactagtCATGACCCCCAA 3' , pUC/M13 Reverse primer:
TCACACAGGAAACAGCT A TGAC3' (PCR 1),
TTGGGGGTCATGactagtcTAGGTCAAACC 3' , pUCIM13 forward primer:
CGCCAGGGTTTTCCCAGTCACGAC 3' (PCR 2) and - 208 OC-CAT as template;
this mutation introduced a unique site for the SpeI restriction enzyme. The PCR
products were digested with BamHI-SpeI (PCR1) and ApaI-SpeI (PCR2). A three way
ligation reaction was set using ApaI-BamHI digested -208 OC-CAT as backbone.
The -208 OC-CAT Runx mutant plasmid was generated by digestion of the mC
CAT plasmid (Javed et aI. , 1999) with SphI-PpMU , followed by blunt ending and self-
ligation. To generate the plasmid with mutations in both C/EBP and Runx (Site C)
binding sites , two PCR reactions were set as above but in this case -208 OC.,CA T Runx
mt was used as template. All plasmids were sequenced using the pUCIM13 forward
primer. The expression constructs encoding the wild type Runx2 and Runx2 361 are
as reported earlier (Banerjee et aI., 1997; Javed et al. , 2001). Runx2 230 was prepared
by PCR amplification of the coding sequences using the forward primer
CGGGATCCATGCGTATTCC3' and a reverse primer with an engineered stop
codon 5' GGCTCGAGTCATTTAGAGTCATCAGGC 3' . Non-encoded nucleotides
are underlined. The PCR fragment was digested with BamHI-XhoI and ligated to
similarly digestedpcDNA 3. 1 His C vector (Invitrogen Inc. , San Diego, CA). In-frame
ligation of these constructs was confirmed by DNA sequencing. Expression constructs
of C/EBP ex, and () were obtained from Dr Alan Friedman (Johns Hopkins Hospital
Baltimore MD).
Generation of the construct carying the VDRE mutation (SHE) has been
previously described (Aslam et aI. , 1999).
Cell Culture, Transient Transfection and CAT Reporter Assays
Normal rat diploid osteoblasts (ROB) obtained from 21 day fetal rat calvariae
were isolated and maintained as described (Owen et aI. , 1990a). HeLa cells were
maintained in Dulbecco modified Eagle medium (Gibco Life Technology, Grand
Island, NY). Rat Osteosarcoma (ROS 1712.8) cells were grown in F12 supplemented
with 5% (v/v) fetal calf serum. HeLa and ROS 17/2.8 cells were plated at a density of
8x 10 cells/well in six well plates and transfected 24 h later with 1- 5 Ilg of either wild
type or mutant reporter plasmids , 100 ng of RSV luciferase and 0. 75 I-g of either
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CMV empty vector, C/EBP , () or Runx expression constructs. The total amount 
exogenous DNA was maintained at 3 Ilg/well with salmon sperm DNA. Cells were
transfected with DNA in the presence of 7 Ill/well of SuperFect (Qiagen Inc., Valencia
II!CA) and incubated at 37 C for 2.5 h with occasional swirling. The transfection mix
was aspirated and cells were washed twice with phosphate buffered saline (PBS) and 'I!
then incubated at 37 C in F12 medium supplemented with 5% (v/v) fetal calf serum
(ROS 17/2.8 cells) or DMEM supplemented with 10% (v/v) fetal calf serum (HeLa
cells) for 24-48 h. Cells were washed twice with ice cold PBS and lysed with 300 III of
Rep0l1er Lysis Buffer (Promega Corp. , Madison , WI) at room temperature for 30 min.
Celllysates were collected and stored at - C or used immediately for CAT assay as
described previously (Frenkel et aI. , 1993). Luciferase activity was determined in the
same lysate with luciferase assay reagents from Promega Corp. (Madison , WI).
Luminescence was quantitated using a Monolite TM 2010 instrument (Analytical
Luminescence Laboratory, San Diego, CA).
Construction Of Stable Cell Lines
ROS 17/2.8 cells with genomically integrated wild type, Runx and VDRE
mutant constructs were generated by the calcium phosphate method (Sambrook and
Russell , 2001). For each construct, four 100 mm plates were transfected with 15 f!gof
the - 1 OC-CA T plasmid and 5 f!g of pCEP-4 (Invitrogen , San Diego , California)
encoding the Hygromycin B phosphotransferase gerie. Cells were harvested at 95%
confluency and replated for selection in media containing 55 U/ml Hygromycin B
(Calbiochem, La Jolla, California) based upon preliminary killing curves. Resistant
colonies (60-75) from each plate were pooled and propagated as polyclonal cell lines.
Each pool was expanded until 20 x 10 cells were available for preparation of frozen
stocks. Monoclonal cell lines were generated by limited dilution of different polyclonal
parental cell lines. Cells were routinely maintained in media containing Hygromycin B
for measuring CAT activi.ty and responsiveness to steroi!i hormones and growth factors.
Stable cells were plated at 2 x 10 cells/well in a six well plate and treated with
10- M vitamin D for 24 h. Cells were washed twice with phosphate buffered saline
and lysed by adding 300 f!l of Reporter Lysis Buffer (Promega Corp. , Madison , WI) at
room temperature for 30 min. CAT activity assays were performed as described above.
Nuclear Extracts And Electrophoretic Mobilty Shift Assay
Nuclear extracts from ROS 17/2. , HeLa and primary rat o teoblast cells at
different stages of culture (d7 , d 14 , and d20) were prepared by a modified Dignam
method (Dignam et aI. , 1983) using 0.42M KCl for extraction. The whole isolation
procedure was carried out on ice. Cells were collected at 95% confluency, washed
twice with ice-cold PBS and pelleted by centrifugation at 70 X g (1 ;600 rpm in IEC) for
5 min at 4 C. Cells were gently resuspended in 5- 10 volumes of NP-40 lysis buffer
(lOmM Tris pH 7.4, 3mM MgCh, 10mM NaCl , 0.5% (v/v) Nonidet P-40 (NP-40))
supplemented with IX C(jmplete
TM protease inhibitor cocktail (Roche Molecular
Biochemicals, Indianapolis, IN), incubated on ice for 20 min and pelleted at 70 X g for
5min. This pellet was washed once with 3 volumes of hypotonic buffer (1 OmM HEPES
pH7.9, 1.5mM MgCh, lOmM KCl , IX C(jmplete ) and extracted for Ih at 4 C in
250-300/l1 of extraction buffer (20mM HEPES pH7.9, 1.5mM MgCh, 420mMKCl
2mM EDT A, 20% (v/v) glycerol , IX C(jmplete); insoluble material was pelleted at
000 X g for 30 min. Aliquots (25 I-l) of the nuclear extracts were snap-frozen in
liquid nitrogen and stored at - C until further use. Protein concentration of nuclear
extracts was determned by Bradford assay. For the electrophoretic mobility shift
assay, the desired amount of nuclear extract was brought up to 10/l1 with KN 100 buffer
(lOmM HEPES pH7. , O.2mM EDTA and 100mM KCl), combined with 10!-1 of a
DNA mixture containing 20 fmol of probe DNA and 1 !-g of poly (dI-dC).(dI-dC) as
non-specific competitor, and incubated at room temperature for 30 min. For
competition experiments , unlabelled double-stranded oligonucleotide (240 to 2000
fmol) was added to the binding reaction with the other components. Samples were
loaded without tracking dye onto a 4% acrylamide: bisacrylamide (30: 1) gel in 0.
Tris borate/EDTA. Electrophoresis was performed for 2 to 2.5 h at 200v. Gels were
dried and subjected to autoradiography.
Studies Of DNase I Hypersensitive Sites And Restriction Enzyme Accessibilty
DNase I digestion and restriction enzyme analysis was performed according to
the indirect end labeling method (Wu, 1980). ROS 17/2.8 cells were plated at a density
of 1 x 10 cells per 100 mm plate and nuclei were isolated on day 9by dounce
homogenization (loose pestle) in eight volumes of RSB buffer (1 OmM Tris HC 1 pH
7.4; 10mM NaCl; 3mM MgCh) with 0.5% (v/v) NP-40. To evaluate cell lysis, an
aliquot of nuclei was stained with 0'.% (w/v) Trypan blue 1: 1 (v/v).
The nuclear suspension was diluted by adding an equal volume of RSB buffer
and nuclei were collected by centrifugation. The pelleted nuclei were resuspended in
RSB buffer and the DNA concentration was estimated by absorption at 260 nm.
Aliquots of 20 A260 units were digested with increasing concentrations of DNase I (0
flit:
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to 5 units) (Worthington Biochemicals, Freehold , NJ) in 1 ml final volume for 10 min
at room temperature , or with 500U/ml of restriction enzyme, in their corresponding
buffer, for 30 min at 37 C. The reaction was stopped by adding EDT A, SDS , RNase
One (Promega, Madison , WI) and Proteinase K (Fisher Biotech, Fairlawn , NJ) to a final
concentration of25mM , 0. 5% (v/v), 1U/ml and 200jlg/ml , respectively, and incubated
at 37 C overnight. The samples were extracted once with phenol:chloroform:isoamyl
alcohol (24:24: 1) and twice with chloroform:isoamyl alcohol (24: 1). Nucleic acids
were precipitated with 2.5 volumes of ethanol at - C for at least 4 h and then
resuspended in 25mM Tris pH 7. 8. DNA was digested with BamHI or Xbal(4 units/jlg
of DNA) to release a 4.3 Kb fragment from the OC gene (Montecino etaI.,. 1996a)or a
7 Kb fragment from the chromosomally integrated pOCZCAT fusion gene
respectively (Frenkel et aI. , 1996). The digested DNA was extracted with
phenol:chloroform, precipitated with ethanol and resuspended in 25mM Tris pH 7.
DNA samples (1 g) were electrophoresed in a 1.2% agarose gel (Biorad, Hercules
CA) and then transferred to a nylon membrane (Hybond N+, Amersham Pharacia
Biotech, Arlington Heights, IL) according to the manufacturer s instructions.
Hybridization probes were prepared by restriction digestion of pOC 3.4 (Lian et
aI., 1989aJ, containing the rat OC gene and flanking sequences, with Xbal-BamHI and
pOCZCAT with Xbal-NcoI. The probes were labelled by the random primer method
using a dCTP and the Stratagene Prime-It II kit (Stratagene, La Jolla, CA).
Hybridization was caried out at 65 C with 1 ng of probe (10- cpm/ g specific activity)
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per lOcm2 membrane. The blots were analyzed by autoradiography or by using a
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STORM Phosphorimager (Molecular Dynamics, Sunnyvale, CA).
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Statistical Representation And Analyses Of The Data
The data for the Runx mutants are displayed as box and whisker plots (Hoaglin
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Ki'i:11 iet aI. , 1983) where the length of the bar represents the range of observations between
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the first and third quarile (i.e., the interquartile range or IQR). The length of the
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observation that does not meet the definition for outlier, i. , a value more than 
IQR' s from either the first or third quartile depending upon whether the observation is
above or below the median.
The distributional characteristics of promoter activities were evaluated
graphically by using histograms and the Kolmogorov-Smimov one-sample test for
Normality (Siegel , 1956). If data were not normally distributed, monotonic
transformations were a lied (i. , natural logarithms) to achieve normality. The
i-l
significance of Runx sites to promoter activity was evaluated using Analysis of
Yariance (ANOY A) for mixed model using restricted estimation by maximum
likelihood (REML) (McLean et al., 1991).
Isolation Of Total Cellular RNA And Northern Blot Analysis
Total cellular RNA was isolated from normal rat fetal calvarial osteoblasts or
adult rat tissues as described previously (Chomczynski and Sacchi , 1987). Cells at
different stages of differentiation were washed and scraped in PBS. Cell pellets were
frozen in liquid nitrogen and kept at - 150 C, once all the time point were collected,
..,
samples were thawed and processed together. RNA pellets were briefly air dried and
1'1
dissolved in 400 !!l of DEPC (Diethylpyrocarbonate) treated water and stored at -
until further usage. RNA samples were electrophoresed in 1 % formaldehyde-agarose
gels and transferred to Hybond-N+ membrane (Amersham Pharmacia Biotech
Arlington Heights , ll) in 20X SSe. Blots were hybridized with random primed (Prime-
It kit; Stratagene, La Jolla, CA), C p) labeled cDNA probes for C/EBPa (NcoI
fragment), C/EBP (EcoRI-XhoI fragment), C/EBP8 (BamHI-EcoRI fragment), human
GAPDH (EcoRI-HindIII fragment), human histone H4 (HindIII-XbaI fragment of
F0108), alkaline phosphatase (EcoRI fragment), Runx2 (BamHI-XbaI fragment) and
rat OC (EcoRI-BamHI fragment) at 42 C overnight. The blots were washed and
subjected to autoradiography.
Immunoprecipitation
HeLa cells were transfected with Runx2 and C/EBP expression constructs;
approximately 1 xJD7 cells per immunoprecipitation (Ip) were lysed in 800 !!l of NP-
buffer (150mM NaCl, 50mM Tris pH 8. , 1 % (v/v) NP-40, IX Opmplete (Roche
Molecular Biochemicals , Indianapolis, IN), 251lM MG132 (Sigma-Aldrich, St. Louis
MO)) and extracted at 4 C for 15 min , followed by centrifugation at 16,000 X g for 15
min. The proteosome inhibitor MG 132 was added to all buffers to avoid degradation
of Runx proteins (Huang et aI. , 2001). The supernatant was trans felTed to a clean
microcentrifuge tube and precleared with 20 III of protein A/G PLUS agarose beads
(Santa Cruz Biotechnology, Inc. , Santa Cruz, CA) at 4 C for 30 min. The beads were
collected by centrifugation at 1 000 X g for 5 min at 4 C. Xpress antibody (3 Ilg,
Catalog #: R91O-25 Invitrogen Corp. , Carlsbad, CA) was added to the precleared cell 1't!t''!
lysate followed by incubation at 4 C for 1 hour. To precipitate the immuno-complexes,
50 III of protein A/G PLUS agarose beads were added and further incubated at 4 C with
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agitation for 1 hour. The beads were washed twice with 1 m1 of washing buffer (20mM
Tris pH 8.3, 0.5% (v/v) sodium deoxycholate, 0.5%(v/v) NoniderP- , 50mM NaCl,
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2mM EDTA, IX Opmplete 251lM MG 132), suspended in 2X SDS sample buffer and
analyzed by Western blotting. Ujl
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Western Blot Analysis
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Transfected or un-transfected HeLa and ROS 17/2. cells cultured on 100 mm
dishes were lysed on the plate by adding 300 III of SDS Lysis buffer (2% (v/v) SDS
lOmM dithiothreitol , 10% (v/v) glycerol , 2M urea, lOmMTris-HCl pH 6. , 0.002%
(v/v) bromophenol blue , IX Opmplete, 251lM MG 132). Proteins (30-40 Ilg) were
resolved in 10% SDS-PAGE and transfelTed to Inlffobilon p (Milipore Corp,
Bedford, MA). Antibodies against C/EBP (sc- 150) and Lamin B (sc-6217) were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz , CA). Epitope tagged
Runx proteins were detected with horseradish peroxidase-conjugated mouse
monoclonal Xpress (R911-25) antibody (Invitrogen Corp., Carlsbad, CA). Monoclonal
antiserum for tubulin (clone DM lA Product N T9026) was purchased from Sigma-
Aldrich (St. Louis , MO).
Chromatin Immunoprecipitation Assay (ChIP)
Chromatin Imunoprecipitation (ChIP) assay was performed as described
li' i':'
elsewhere (Soutoglou and Talianidis, 2002) with some modifications. Cells were
treated with 1 % (v/v) formaldehyde at 37 C for 10 min. Crosslinking was stopped by
!,:
adding glycine to a final concentration of 0. 125M. Cell were washed with ice cold
rii
PBS , collected by centrifugation at 165 x g for 5 min at 4 C. The cell pellet was Ii!!'li;!
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resuspended in lysis buffer (25mM HEPES pH7. , 1.5mM MgClz, 10mM KCI , 0. 1 % III
(v/v) NP-40, IX C(jmplete, 25f.M MG- 132) and incubated on ice for 10 min.
Following dounce homogenization (20 strokes, pestle A), the nuclei were collected by
centrifugation at 750 x g for 5 min, resuspended in sonication buffer (50mM HEPES
pH7.9, 140mM NaCl , ImM EDT A, 1 % (v/v) Triton X- 100 , 0. 1 % (v/v) Na-
deoxycholate , 0. 1 % (v/v) SDS , IX C(jmplete , 25f.M MG- 132) and sonicated on ice to a
DNA size of 200-800 bp. The samples were centrifuged at 16,000 x g for 15 min and
prec1eared with AlG plus- agarose beads precoated with 2f.g sonicated salmon sperm
DNA and Img/ml BSA (or at least one hour at 4 C. 30A 60 units of the prec1eared
chromatin were immunoprecipitated with 5f.g of antibody and the immuno complexes
were collected by binding to AlG plus- agars beads. The beads were washed twice with
each of the following buffers: sonication buffer, sonication buffer containing 500mM
NaCl, LiCl buffer (20mM Tris pH 8 , ImM EDT A , 250mM LiCl, 0.5% (v/v) NP-AO
5% (v/v) Na-deoxycholate) and 10mM Tris pH 8. The il1uno complexes were
eluted in 50mM Tris pH 8, ImM EDT A and 1 % (v/v) SDS at 65 C for 15 min , adjusted
to 200mM NaCl and incubated overnight at 65 C to reverse the crosslinking.
Following treatment with RNase One (1 U/ml) and Proteinase K (20Ilg/ml), the samples
were purified using PCR purification kit from Qiagen Inc. One tenth of the
immunoprecipitated DNA and input DNA were analyzed by PCR using oligos
;r;
described in Table 4.2. PCR amplifications (26 cycles) were performed in the presence
of O. IIlCi u dCTP per reaction and the products were resolved in 4% if'
~~~~
polyacrylamide gels.
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!:!t!The antibodies used for ChIPs were anti-acetyl-Histone H3 (Catalog # 06-599),
anti-acetyl Histone H4 (Catalog # 06-866) from Upstate Biotechnology and anti
phosphorylated RNA Pol II CTD-Ser-2P (Clone H5, Catalog # MMS- 129R) from
1ti'
Covance Inc.
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INTRODUCTION
Bone tissue-restricted expression of the osteoca1cin (OC) gene during
development of the osteoblast phenotype requires a multiplicity of transactivating
factors. Among the key regulators of osteoca1cin expression are transcription factors
that play essential roles in embryonic formation of the skeleton and osteoblast
differentiation. These include the Runx (Runt related proteins)/ Cbfa (core binding
factors a)/AML (acute myelogenous leukemia) family of 
runt homology domain
!i,
!,Ji
(RHD) DNA binding proteins (reviewed in (Komori , 1998)), the Msx and Dlx
homeodomain proteins (Hoffmann et aI. , 1994; Towler et aI., 1994b; Ryoo et aI. , 1997),
AP- 1 proteins (McCabe et aI. , 1996) and steroid hormone receptors (reviewed in (Lian
et aI. , 1999a)).
The Runx family of transcriptional activators is critical for the development of
hematopoietic and skeletal tissues. Three known genes, 
Runx3 (Cbfal/hAML-
3/mPebp2a), Runx 1 (Cbfa2/hAML- l/mPebp2b), and Runx3 (Cbfa3/hAML-
2/mPebp2c), each encode several mRNA splice variants (Speck and Stacy, 1995; Ahn
et aI., 1996; Levanon et aI., 1994). The tissue-specific transcriptional properties ofthe
Runx proteins are in part accounted for by their selective representation in distinct
cellular phenotypes. Runx 1 primarily regulates expression of genes related to the
development of thymus and hematopoietic tissues, and a null mutant of this gene results
in embryonic lethality due to absence of definitive hematopoiesis. Several isoforms 
Runx2 have been described; one is expressed in hematopoietic tissues (Zhang et aI.
1997b) and another is highly expressed in osteoblast lineage cells of bone (Stewar et
al., 1997; Xiao et aI., 1998; Thirunavukkarasu et aI., 1998; Ducy et aI. , 1997; Banerjee
et aI., 1997) and in hypertrophic chondrocytes (Komori et aI. , 1997). Ablation of the
Runx2 gene in mice reveals the importance of this factor in development of the
skeleton with a consequent absence of mineralized connective tissues (Komori et aI.
1997; Otto et aI. , 1997; Mundlos et aI. , 1997). The Runx class ofRHD proteins was
initially identified in bone as an osseous cell-specific DNA binding complex extracted
from the nuclear matrix (Bidwell et aI., 1993; Merriman et aI., 1995). Subsequently,
, Runx proteins were shown to regulate tissue-specific expression of the osteoca1cin
promoter (Banerjee et aI. , 1996a; Ducy and Karsenty, 1995). Although overexpression
f'J
of the Runx 1 , Runx2 or Runx3 factors in non-osseous cells can confer expression of the
bone-specific osteoca1cin gene (Banerjee et aI. , 1996a), the DNA binding activity
present in mature osteoblasts consists primarily of the Runx2 gene product (Banerjee et
.,\,
RI.
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aI., 1997; Ducy et aI. , 1997).
The bone-specific rat osteoca1cin promoter contains three recognition sites for
Runx interactions (sites A , Band C (Merriman et aI. , 1995)). Notably, all three motifs
bind a similar osteoblast-specific DNA binding complex, first designated NMP-
(Merriman et aI. , 1995; Bidwell et aI. , 1993). While only one Runx site fused to a
minimal OC promoter is sufficient to confer enhancer activity in osseous and non-
osseous cells (Banerjee et aI. , 1996a), the presence and positioning of multiple Runx
sites suggest that spatial organization of the native OC promoter may be important for
interaction of Runx proteins with other OC promoter regulatory factors. For example
transcription of the rat and human osteoca1cin genes is strongly influenced by 1 25-
dihydroxyvitamin D. Runx sites A and B flank the vitamin D response element which
mediates 3- 10 fold enhancer activity of the rat and human promoters. A third Runx site
C (also designated OSE2 in mouse (Ducy and Karsenty, 1995)) is located in the
proximal promoter (nt - 136 to - 130). A positioned nucleosome resides between Runx
sites Band C in .the transcriptionally active rat osteocalcin promoter (Montecino et al.
1996b). Because Runx factors associate with the nuclear matrix (Stein et aI. , 1997) and
can recruit other factors into complexes (Palaparti et aI. , 1997; Aronson et aI. , 1997;
Levanon et aI., 1998; Speck and Stacy, 1995; Ito , 1997), Runx binding sites may
impose structural constraints on the osteoca1cin promoter to facilitate interaction and
activities of the proximal and distal regulatory elements (e. , the VDRE and T ATA
domains). The function of the Runx motifs within the context of the native rat
osteoca1cin promoter has yet to be examined.
In these studies, we establish that all three Runx elements within the rat OC
promoter contribute to basal transcriptional activity, suggesting a functional interaction
among the three sites. In contrast to recent studies of the mouse OC promoter (Frendo'
et al., 1998), the distal site A (nt -605/-599) in the rat OC promoter contributes far more
to Runx, dependent promoter activity than the proximal site C/OSE2. Furthermore , the
presence of the upstream Runx sites is critical for vitamin D induction of osteoca1cin
promoter activity. Mutation of all three Runx sites results in altered chromatin
organization ,as reflected by loss of DN ase I hypersensitive sites in the OC promoter.
These findings suggest that transcriptional activity of the OC gene, which requires
interactions Qf proximal and distal regulatory elements, may be facilitated through
spatial constraints of the promoter imposed by the binding ofthe nuclear matrix
associated Runx factors to critically positioned recognition sequences.
RESULTS
Full Basal Activity Of The Osteocalcin Promoter Requires The Distal Runx Sites
A single Runx element is suffcient to confer tissue-specific transactivationof
the proximal osteoca1cin promoter (Banerjee et aI. , 1996a; Ducy et aI., 1997). To
address the contributions of the multiple Runx sites in the native rat OC promoter to
osteoca1cin transcription , we carried out site-directed mutagenesis of each of the three
Runx elements, designated sites A. Band C (Fig. 3. 1). Initially, we established two-
nucleotide substitution mutations in the core of each OC Runx site, which abrogate
bone-specific Runx binding activity (Fig. 3.2). The appropriate WT and mutant
\iit;
l\'i
oligonucleotide sequences for each site (shown in the Methods section) were examined
in gel mobility shift assays using nuclear extracts from ROS 17/2.8 rat osteQsarcoma
~~~~
cell lines. These extracts contain abundant levels of Runx2 , which forms an osteoblast- lh'"
specific complex that can be supershifted by Runx2-specific antibody (Banerjee et aI., W:;!
1996a; Banerjee et aI. , 1997). Figure 3.2A demonstrates that each mutation results in
!:.': 
loss of the Runx binding complex. Because competition of binding to the WT sequence
is not observed in the presence of 80 fold excess (lnM) of mutant oligonucleotide
representing sites A, B or C (Fig. 3.2B , lanes 5- , respectively), the mutations have
completely abrogated Runx binding.
The locations of the Runx sites within the rat OC promoter (Merriman et aI.,
1995) suggest different activities, while promoter deletion analysis (Banerjee et aI.,
1996a; Hoffmann et aI. , 1996) indicates redundant function for the multiple Runx sites.
The functionality of each site was therefore tested following transient transfection of
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Figure 3.2 Mutations of the three rat osteocalcin Runx sites result in Joss of
Run bindin: (A) Panel compares formation of the osteoblast specific complex
from nuclear extracts of ROS 17/2.8 cells with oligonucleotides containing wild
tye (WT) sequences representing Runx site A (lane 1), site B (lane 3), and site C
(lane 5) and mutated (M) Runx sequences of sites A (lane 2), B (lane 4), and C
(lane 6) in gel mobilty shif assays. Runx complexes are indicated by solid
arowheads. A non-specific complex (site B) is indicated by an open arrowhead.
(B) Panels site A, site B, and site C show cOITesponding competition assays for
each Runx site using the wild type sequence as probe with increasing amounts (0,
20, 60, 80X) of either wild type (WT) oligonucleotide (lanes 1- , respectively) or
Runx site mutated oligonucleotides (lanes 5- 8, respectively) as competitor.
5 6
the WT and mutant OC promoter (- 1.1 kb) constructs into ROS 17/2.8 cells (Fig. 3.3B,
and Table 3. 1). Activity of the OC WT promoter was compared to activity of
promoters having single or multiple Runx site mutations. While mutation of each of
the sites reduced promoter activity compared to control , mutation of the proximal site C
had the least effect (83% of WT , p value of 0.206 is non-significant). Mutation of sites
A and B independently or of the two sites AB and AC, reduced promoter activity to
approximatel y 50% of the WT , but high statistical significance of the, effect was found
in these transient assays only for mAB (p.:0.001). Transcriptional activity ofthe Runx
three-site mutation, mAC , was decreased to 40% of the control level (p.:0.001).
To determine the contribution of the Runx sites to OC gene promoter
transcription within a genomic context, we established a series of ROS 17/2.8 cell lines
which contain stably integrated OC-CA T reporter gene constructs with single , paired or
triple Runx mutations in the - 1.1 kb rat OC promoter (Fig. 3.3A). As described in
Materials and Methods, we examined four independent pools of cell lines for each
construct to compensate for positional effects on promoter activity. Due to site-of-
integration effects and copy number, basal activity for each cell pool varied among the
cell lines over a 2-fol range. Figure 3.3C shows that mutation of each of the
individual Runx sites resulted in significantly decreased promoter activity, with
reductions in transcription greater than those observed following transient transfection
(Fig. 3.3B). Again , mutation of the proximal site C minimally affected transcription;
even as a stable integrant in osteoblasts (p.:0.05). Mutations involving site A had a
more pronounced effect in decreasing promoter activity in the stable cell lines (from
20-30% of control , p.:0.001). This conclusion is further supported by the finding that
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Figure 3.3 Requirement for multiple Runx sites for maximal transcriptional
activity of the rat osteocalcin gene promoter: (A) 1.1 kb of rat OC 5'
sequences containing either single or multiple site mutations are schematically
ilustrated. Single site mutations are designated mA, mB , or mC , two site
mutations mAB , mAC or mBC and mABC is the triple mutation.
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Figure 3.3 Requirement for multiple Run sites for maximal transcriptional
activity of the rat osteocalcin gene promoter: (B) Following transient
transfections in ROS 17/2.8 cells, normalized CAT-reporter activity of the WT
promoter and promoters with Runx site mutations are compared. Reporter activity
was assayed 24 hr after transfection ofROS 17/2. 8 cells. The C CAT activity was
quantitated by a Betascope analyzer (Betagen,Waltham, MA) and normalized to
luciferase. (Aliquots ofthe lysate were assayed for luciferase activity to normalie
CAT activity.) Each bar represents the LS mean:t SEM (n=12). Single asterisk
indicates statistically less than WT p-=0.001; double asterisk, p-=O.Ol.
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Figure 3.3 Requirement for multiple Run sites for maximal transcriptional
activity of the rat osteocalcin gene promoter: (C) Activity of WT and Runx
sites mutated proIIters stably integrated into ROS 17/2.8 cells. Each group
represents proIIter activity in 4 independent cell lines, with each cell lie
assayed in 4 separate experiments in tdplicate. Cells were havested 3 days after
plating as cells reached IInolayer confluency for quantitation of CAT aCtivity
normalized to total protein of the cell lysate. Each bar represents the LS rran :t
SEM (n=18). The pGEM control represents a proIIterless CAT containing
stable cell line. Single asterisk indicates statistically less than WT p.cO.OOl;
double asterisk, p.cO.01.
TABLE 3.
CONTRIBUTION OF DISTAL Runx SITE A AND
SITE B TO OC PROMOTER ACTIVITY
p Values for activity of Runx sites
tested against all groups
n,,
"'l
Effect of Each
WT Site
m;"
Stable Cell LinesTransient Assays
O. 000 1
;ii ;!!i
O. 000 1
0001
CI;
~~~
O. 000 1 . '1-I":\ ..
tt.;,
:i:W
O. 000 1
Interactions
Between Sites
A with B t
A with C t
B with C t
A with B with C t
n:f'
l.'
'J!J!-I-
:!' :,'
ir.:!f!
00 13 000 1
0062
0001 000 1
ICW
.1di'
!1!
:;i
1,'1.
s. Not significant (Le. , ::0.05).
The interactions between the indicated sites were tested for significance. When
sites A and B or A, Band C are present together in transient assay or stable cells and
sites A and C' are present together in a genomic context , the, presence of the other
site(s) influences the contribution to transcriptional activity of the promoter.
H6:
transcription of mBC is only reduced to 80% of control , indicating that site A
contributes a significant level of Runx dependent activity to the OC promoter (Fig.
3C). Because all possible mutation groups were examined and sample sizes within a
group were large , the statistical significance of the contribution of each Runx site to OC
promoter activity could be compared (Table 3. 1). On the basis of whether each of the
sites is present or absent in a construct, the effect of site A or B , but not C, was always
significant. Furthermore , two way ANOV A of the LS mean of each group revealed 
significant interaction between sites A and B. There is a 2 to 3 fold greater effect
contributed by site A when site B is present and by site B when site A is present.
Taken together, these findings indicate that all of the Runx sites in the rat OC promoter
contribute to basal transcription and that the distal sites A and B play predominant roles
in supporting promoter activity within a chromosomal context.
~~~
Functional Compensatory Activity Of The Three Runx Sites In Osteocalcin
Transcription r.;9
The mutagenesis studies suggest that the distal sites A and B provide a
significant level of functional activity and that the proximal site C does not contribute
equally to basal promoter activity. To further assess involvement of each of the three
"".,
Runx sites in transcription of the rat osteoca1cin gene , we examined the consequences
of forced expression of Runx2 on activity of wild type and mutant promoter constructs
in non-osseous cells , which do not express osteoca1cin. In HeLa cells , for example , OC
promoter activity is very low , and transcription factors necessary for bone tissue-
specific expression are unlikely to be present. Runx forced expression in HeLa cells
results in detectable wild type OC promoter activity (3.3 fold induction, Fig. 3.4); as
II Control
Run 2
pOCZCAT mA mAC mA mAC mBC
Constructs
Figure 3.4 Runx2 mediated transactivation of OC promoters containin mutated
Run sites in HeLa cells: 0. g of Runx2 expression plasmid and indicated OC-
CAT plasmids (2. g) were co- transfected into HeLa cells and assayed 36 hours
following transfection. The CAT activity was quantitated by direct counting using a
Betascope analyzer (Betagen, Waltham, MA). CAT activity was calculated as
percent conversion and normalized for luciferase values used as internal control. 
statistically significant difference (pocO.OOl) of the mABC group to WT is indicated
by as terisk.
expected, mutation of all three Runx sites dramatically reduces Runx dependent OC
promoter activity. In contrast, mutation of the single sites A, B or C resulted in
induction of OC promoter activity to approximately the same extent, but somewhat less
than wild type. Together these findings suggest that anyone of the three sites can
support induction of the OC promoter when cellular levels of Runx2 are available.
However, compensatory effects are partial, indicating that all three sites are necessary
for maximal promoter activity. Thus , these findings indicate that Runx-dependent
induction of promoter activity at each Runx site is similar, suggesting functional
compensatory activity. Notably, the mutational analyses support a selective
contribution of the distal sites versus the proximal site C to basal promoter activity (see
Fig: 33).
Steroid Hormone Modifcation Of Transcription Is Dependent On Rtinx2
Regulatory Elements
;L,':,
Our mutational studies suggest that the two distal Runx sites , which flank the
vitamin D response element (VDRE), are essential to basal expression of the
osteoca1cin gene (Fig. 3.3C). The VDRE is a strong enhancer of OC transcription and
vitamin D responsiveness necessitates interaction of the VDR/R heterodimer Li:"'
;::n
complex at the distal VDRE (nuc1eotides -461/-441) with TFIil and other general
transcription factors at the proximal TAT A binding element (nuc1eotides -32/-29). We ):r
;:: 
therefore addressed the potential contribution of Runx sites in mediating vitamin D
responsiveness within the context of chromosomal integration of the OC promoter in
stable cell lines. The importance of examining vitamin D responsiveness as influenced
by the Runx motifs within a chromosomal context is supported by our previous studies
iii
demonstrating the presence of a positioned nuc1eosome between Runx sites Band Con
the osteoca1cin promoter and increased DNase I hypersensitivity in response to vitamin
D (Montecino et al., 1996a; Montecino et aI., 1996b).
Expression of the stably integrated WT promoter was enhanced by vitamin D
from 4 to 7 fold in the four stable cell line pools , independent of basal promoter activity
(Fig. 3.5). In striking contrast , the four stable cell lines in which all three Runx sites of
the integrated OC promoter were mutated (mABC cell line, designated T 1 to T 4, Fig.
5) exhibited nearly complete inhibition of vitamn D stimulation of transcription
(summarized in Fig. 3.6A). This abrogation of vitamin D responsiveness of the mABC l'r
promoter was also observed following transient transfectionofthe WT and mABC
promoters into ROS 1712. cells (Fig. 3.6B). In three different experiments (total
n= 18), the mean folds induction of the WT OC promoter by 10- M 1 25 (OH)2 in 24
his 7.4 (:10.2 standard deviation (SD)) but only 1.6 (:t.3 SD) for the mABC construct.
We then proceeded to examine the contribution of each Runx site to vitamin D
f:t1
dependent promoter activity. Mutation of anyone of the single Runx sites (mA, mB, or
mC) decreased the vitamin D response from 5 fold induction (WT) to 2.5 and 2.8 fold
induction for mutant sites A and C , respectively, and 1.9 fold stimulation with mutant
site B (mB) (Fig. 3.6). When vitamin D responsiveness of the paired mutations was
examined (Fig. 3.6), the contribution of the distal sites to functional activity of the
VDRE was further defined. Notably, the mA two-site mutation nearly eliminated
vitamin D stimulatory activity, similar to the effect of the triple mutant. In contrast
two-site mutations involving the proximal site C (mAC and mBC) had less effect
reducing vitamin D responsiveness to 2.5 and 3 fold induction respectively, similar to
o 0
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Figure 3.5 Loss of vitamin D responsiveness of the rat osteocalcin promoter
with three mutated Runx sites (mABC): (A) Four independent ROS 17/2.8 cell
lines with stably integrated WT promoters (WTI' WT , WT3' WT ) and the triple
Runx site mutation (mABC) cell lines , designated as T I' T , T , T , were treated 3
days after plating for 24 hours with 10- M 1 25(OH)2 and assayed for CAT
' ,
activity normalized to total protein in the cell lysate. Each bar represents mean
value of n=3 determinations.
WTl WT2 WT3 WT4
Stable Cell Lines
, ,
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Stable Cell Lines
Figure 3.6 Distal Runx sites A and B in the osteocalcin promoter are required for
vitamin D enhancer activity: (A) ROS 1712. cell lines containing stably integrated wild
type and indicated Runx mutant promoter-CAT reporter constructs were examined for
responsiveness to vitamin (10- M, 1 25(OH)2 , 24 hrs). pGEM control is a
promoterless-CA T stable cell line. Enhancer activity of vitamin D (vitamin D-
treated/control non-treated cells) is reported as fold induction. Each bar represents pooled
data from n=3 or 4 separate cell lines, each assayed in triplicate in 2 to 4 independent
experiments. Single asterisk designates pc:O.OOl statistical significance of mutant cell line
versus WT.
Figure 3.6 Distal Runx sites A and B in the osteocalcin promoter are required for
vitamin D enhancer activity: (B) ROS 17/2.8 cell transiently transfected with wild type
and indicated Runx mutant promoter-CAT reporter constructs were examined for
responsiveness to vitamin D (10- M, 1,25(OH)2 , 24 hrs). Enhancer activity of vitamin D
(vitamin D-treated/control non-treated cells) is reported as fold induction. Each bar
represents pooled data from three different experiments (n=18).
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the consequences of the single site C mutation. Thus, these results confirm a critical
role for sites A and B , not only in basal expression of the OC promoter, but also in
vitamin D regulation of osteoca1cin promoter activity. These findings suggest that the
Runx sites support structural organization of the osteoca1cin promoter that is permssive
for interaction of the distal VDRE and proximal TAT A binding factors required for
enhancer activity of the VDRlXR complex (Haussler et al. , 1997; Stein et aI. , 1997;
Guo et aI. , 1997).
Runx Binding Factors Contribute To Chromatin Organization Of The OC
Promoter
Previous studies caried out by our laboratory have shown the presence of
DNase I hypersensitive sites in the native OC promoter as well as in the transgene of
'1'1
stable cell lines with an integrated OC promoter-CAT gene (pOCZCA T) (Montecino et
aI. , 1994b; Montecino et al. , 1996a; Montecino et aI. , 1996b). These promoters exhibit
two DNase I hypersensitive sites, designated DHS I in the basal promoter region and
DHS IT in the distal promoter encompassing the VDRE. The nuclease accessibilty of
both regions is functionally related to the extent to which the OC gene or the transgene ", I
(pOCZCAT) is expressed. Based on these findings and the observation that the triple ."1
Runx mutant (mABC) does not respond to vitamin D, we examined the effect of this
mutation on nuclease hypersensitivity of the OC promoter. Figure 3.7 shows the
consequences of DNase I digestion of nuclei from the ROS 17/2.8 cell line carrying the
wild type 1. 1 kb rat OC promoter trans gene. Two DNase I hypersensitive sites are
present both in the control cells and in cells treated with vitamin D (Fig. 3.7C). An
increase in the DNase I hypersensitivity is observed following vitamin D treatment. In
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Figure 3.7 DNase hypersensitive profie of WT OC promoter: (A)
Diagrammatic ilustration of the OC promoter-CA Ttransgene showing the regions
used as probes. (B) Schematic representation of the endogenous OC gene showing
the Bam HJ.Xba I fragment used as probe.
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Figure 3.7 DNase I hypersensitive profie of WT OC promoter: Nuclei were isolated
from untreated (left panels) and vitamin D-treated (10- M 1 25(OH)2 ) for 24 hours. (right
panels) ROS 1712. stable cell lines having the 1.1 kb rat WT OC promoter. Nuclei were
incubated with increasing amounts of DNase I from 0 to 5 units per 20 OD260 units of
nuclei for 10 minutes at room temperature. DNase I concentrations (U/ml) are designated
above the lanes of the Southern blot. The purified DNA was digested with Xba I to detect
the transgene either with a Xba I-Nco I (C) or a Xba 1- Ban I probe (D) and digested with
BamH I to detect the endogenous gene with a Bam HI-Hind III probe (E). M represents
markers from A DNA digested with Hind III and EcoR 1. The two DNase I hypersensitive
sites (DHS I and DHS II) are indicated by filled arowheads.
. 
contrast, DNase I hypersensitive sites are not detected in nuclei from either untreated or
vitamin D treated cells carrying the mAC OC promoter-CAT trans gene (Fig. 3. 8A).
The specificity of the DNase I hypersensitive sites was confirmed by reprobing the blot
with a OA kb fragment (XbaI-BanI) that detected the vector backbone (Fig. 3.7D).
To ensure that the complete loss of DNase I hypersensitivity in mABC is not
due toa nonspecific alteration of the promoter, we examined the DNase I profile of
mutant BC , which retains significant basal activity and vitamin D responsiveness (Fig
3 and 3.6). Interestingly we observed DNase I hypersensitivity in the distal domain
(DHS II), which encompasses the VDRE (Fig. 3.9). Thus there is a correlation between
vitamin-D enhanced transcription and the level of DNase I hypersensitivity. The
competency of the mBC cell line to respond to vitamin D suggests that the ability of
VDR receptor complex to interact with it specific binding sequence in the OC promoter
remains intact. Significantly, in mBC , the proximal DHS I that resides over the
mutated site C is very weak. Therefore modifications in DNase I hypersensitivity are
linked to mutations in Runx sites. Together these results demonstrate that the
chromatin structure of the OC promoter requires the integrity of the Runx sites.
The specificity of the contribution of Runx elements to chromatin structure is I)', I
further demonstrated by the DNase I hypersensitivity of the native gene in the mABC
i1;"
1',
:i!:::1
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Ii.,
rff
cell line (Fig. 8B). The endogenous OC gene in the mABC mutant cell line retains
DNase I hypersensitivity, which increases upon treatment with vitamin D. Sinllar
responsiveness of the endogenous OC gene to DNase I was observ d in the cell lines
carrying the WT or the mBC transgenes (Fig. 3. , 3.9B). A schematic ilustration
summarizing these modifications in DNase I hypersensitivity of the WT and riBC
mABC
Endogenous
0Kb
U DNase I/ml
DHS II
DHSI
DHS II
DHSI
Figure 3.8 DNase I hypersensitive profie of mABC stable cell line: Nuclei
isolated from control and vitamin D treated cells carrying the mABC trans gene
were digested with DNase I as described in figure 7. Notice the absence of DNase I
hypersensitive sites in the transgene (A). Panel B shows the DNase I profie of the
endogenous gene aS control.
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Figure 3.9 DNase I hypersensitivity profie of roC stable cell line: Nuclei isolated
from control and vitamin D treated cells carring the mBC trans gene were digested
with DNase I as described in figure 3.7. DNase I hypersensitive sites in the transgene
(A). Panel B shows theDNase'l profie ofthe endogenous gene as control.
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OC promoters is presented in figure 3. 10. These studies provide compelling evidence
that Runx factors are determnants of chromatin organization that supports
transcriptional activity of the OC promoter.
DISCUSSION
The osteoca1cin gene promoter provides a blueprint for defining factors that
regulate osteobl st-specific expression of the gene. These factors contIibute to the
complexity of molecular mechanisms associated with develppment. of the osteoblast
phenotype. We and others (Banerjee et aI., 1997; Banerjee et aI., 1996b; Hoffmannet
aI. , 1994; Towler et aI. , 1994a; Towler and Rodan , 1995; Towler et aI., 1994b), have,
previously shown by deletion analysis of the rat osteocalcin promoter from - 1.7 kb to -
108 bp that a significant loss of transcriptional activity occurs when the proximal Runx
site C is not present. This observation suggests either that there is functional
redundancy of the Runx sites or that the distal recognition sites do not contribute to
promoter activity. To understand the contribution of Runx factors to regulation of
osteocalcin gene transcription, it was necessary to address function of the multiple
Runx sites in the native osteocalcin promoter.
Our studies have established the importance of the distal Runx sites A and B to
activity of the rat osteocalcin promoter in a genomic context. We used a series of cell
lines with stable integrants of the - 1 kb OC promoter or with site-specific mutations
of each Runx sequence alone, as well as combinatorial mutations of two or all three
Runx sites. While transient transfection assays have greatly expanded our knowledge
of transcriptional mechanisms regulating gene expression , such transfected promoter-
Inactive Osteocalcin Gene
Active Osteocalcin Gene
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Figure 3.10 Illustration of modifcations in chromatin organization of the rat
osteocalcin promoter: Top line diagrams a random array of nucleosomes across - 1 kb
of the rat osteoca1cin promoter in cells which do not express OC, established by
micrococcal nuclease digestion (Montecino 1996). Second line diagrams the actively
transcribed OC promoter showing the span of two DNase I hypersensitive (DHS) sites
together with regulatory elements in the proximal and distal DHS sites. The extent of
DNase I hypersensitivity is compared for basal OC expression (WT -basal) and vitamin D
treated (WT-vitamin D enhanced) osteoblasts (ROS 17/2.8) cells. No DHS -
nondetectable DNase I HS in non-osseous cells or of the mABC OC promoter in
osteoblasts. 
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reporter constructs may not completely reflect regulation of endogenous genes.
In stable integrants of the OC promoter in ROS 17/2.8 cells, mutation of either site A or
B results in a significant loss of promoter activity. Mutation of the proximal site C
(OSE-2 (Ducy and Karsenty, 1995)) alone has the least effect in modifying bone-
specific basal activity of the OC promoter, suggesting strong compensatory activity by
the distal Runx sites. However, when we carried out Runx expression studies to
confirm the importance of each Runx site , the results demonstrated that all three sites
are necessary for maximal basal promoter activity. The more pronounced effects of the
Runx site mutations observed when the OC promoter is stably integrated into the
genome of ROS 17/2.8 cells suggest that the chromatin context strongly influences
activity of the promoter.
Our results indicate that regulatory elements other than Runx sites contribute to
osteoca1cin gene transcription. We find that in transient assays , 40% of wild type OC
promoter activity remains when Runx sites A , Band C are mutated (mABC , Fig. 3.3B),
while 20% activity is retained by the mABC mutant in stable cell lines (Fig. 3.3C).
This residual promoter activity of mABC is consistent with results from promoter-
deletion analysis ofthe rat OC gene (Hoffmann et aI. , 2000; Hoffmann et aI. , 1996) and
reflects the contribution of the highly conserved OC Box I (-99/-76) regulatory element
which is also necessary for tissue-specific basal expression.
The major products ofthe various Runx/AML genes have several shared
domains that contribute to transcriptional regulation of tissue-specific genes; the Runx
factors may function as architectural proteins that serve to assemble macromolecular
complexes involved in gene regulation. These structurally and functionally
homologous segments include the conserved DNA binding runt homology domain
transcriptional activation and suppression domains (Hiebertet aI., 1996; LenIiy et al.
1995; Meyers et aI. , 1996), as well as subcellular targeting signals (Ito, 1997; Zeng et
aI. , 1997). The promoter organizing functions of Runx factors may involve Runx-
interacting proteins , including Cbfl (Banerjee et aI., 1996a;Banerjee et al. , 1997;
Kanno et al. , 1998; Speck and Stacy, 1995), ALY (Bruhn et aI., 1997), and
Groucho/TLE (Aronson et aI., 1997; Guo et aI. , 1998; Levanon et al. , 1998;
Thirunavukkarasu et aI., 1998). Interestingly, Groucho/TLEproteins have been shown
to contact the N-terminus of histone H3 (Fisher and Caudy, 1998; Palapari etal.
1997). The Runx class of transcription factors has also been shown to associate with
the nuclear matrix (Ito , 1997; Zeng et aI. , 1997; Zeng et aI. , 1998), the structural
scaffold ofthe nucleus, through a 31 amino acid nuclear matrix targeting sequence
: ;'. .
(NMTS) in the C termnus of full length Runx isoforms ((Zeng et aI. 1997) and
. .
unpublished data). The NMTS directs Runx factors to transcriptionally active
subnuclear sites (Zeng et aI. , 1998), similar to the NMTS-dependent targeting of the rat
. ';!'
glucocorticoid receptor (Tang et aI. , 1998). Together, the multiple protein'-protein
, ,
,II'
interaction domains of Runx factors may operate by a promoter architectural
mechanism to functionally support physiologically regulated expression of the tissue-
! -
specific osteoca1cin gene. :' i
: j\.j;
We have shown that mutation of the Runx sites results in a striking loss of
..:
responsiveness of the rat OC promoter to vitamin D and other physiological mediators
of osteoblast differentiation, including glucocorticoids and TGF (Javed et aI., 1998).
These signaling molecules regulate OC transcription through, respectively, VDRlRXR
GR, and AP- 1 factors that act at non-Runx elements. Furthermore, mutation of the
three Runx sites results in complete loss of DNase' I hypersensitivity and the dynamic
vitamin D-dependent modifications in chromatin structure, which are essential for
normal activity of the OC promoter. Indeed , a similar absence of DNase I
hypersensitivity is observed in the silent endogenous OC gene within non-osseous cells
(Fig. 3. 10). Therefore , the competency of this promoter to undergo chromatin
remodeling for maximal transcriptional responsiveness involves key contributions of
Runx factors. Our results are consistent with the concept that Runx factors contribute
" ,
to a promoter conformation that mediates accessibility or recruitment of factors to DNA
regulatory elements.
Steroid hormone-dependent transcriptional activation is known to involve
; I
modification in chromatin organization. In the rat OC gene, we have established that
binding of the vitamin D-liganded VDR/R complex to the VDRE in the distal
promoter induces architectural changes in chromatin that facilitate requisite interactions
with the proximal basal promoter complex (Guo et aI. , 1997; Zhou et aI. , 1994).
Glucocorticoid regulation of the MMTV promoter (Beato, 1996; Fragoso et aI. , 1998;
Smith et al. , 1997; Truss et aI. , 1996; Zaret and Yamamoto , 1984) involves the GR-
mediated conversion of arepressive chromatin state to an ' open configuration allowing
NFl and Oct! access to their binding sites. Subsequently, activation of transcription
occurs through interactions of GR with the TFIil basal complex (Archer et aI. , 1992;
Smith and Hager, 1997). The results presented here suggest that interaction of the OC
promoter with the nuclear matrix-associated Runx2 factor is an essential step for steroid
hormone-dependent activity of the OC promoter.
The significance of the three Runx sites in the rat osteoca1cin promoter, two of
which flank the VDRE , in contributing to maximal expression and physiologic
responsiveness of the gene is highlighted BY the opposing effects of vitamin D on the
mouse DC promoter (Clemens et aI., 1997; Lian et aI. , 1997; Zhang et aI. , 1997a).
Vitamin D does not mediate enhanced activity of the mouse DC promoter (Zhouet al.,
1994) and, in fact, the mouse 'DC VDRE exhibits weak downregulation by the hormone
(Lian et al. , 1997). Consistent with this finding, the mouse VDRE sequence is not
flanked by two functional Runx sites as occurs in the rat DC promoter. In the mouse.
DC promoter, the distal Runx site resides upstream of the VDRE in a similar position
as in the rat promoter (nt -608 to -602), but site B (-441 to -435 in the rat), which is
critically involved in vitamin D regulation of the rat promoter, is not present in the
mouse promoter (Frendo et aI. , 1998). Mutational analysis of the mouse Runx sites has
established that the distal site contributes far less to transcription than the proximal
Runx/DSE2 site (Frendo et aI., 1998). Clearly, our studies demonstrate that the distal
Runx A and B sites are important for basal activity of the rat DC promoter and essential
for vitamin D responsiveness. The subtle differences between mouse and rat in
organization of Run x motifs may be necessary to regulate DC expression and
responsiveness to physiologic mediators of bone formation and turnover at different
levels dependent on the species. Thus, caution must be exercised when generalizing
conclusions with respect to regulation of osteoca1cin promoters from different species.
Many tissue-specific genes contain multiple Runx sites which are strategically
positioned relative to other cis-acting elements (Gao et al., 1998; Ji et aI. , 1998;
Selvamurugan et aI. , 1998). This heterogeneity in promoter organization of Runx-
dependent genes, together with a series of context-dependent activation domains in the
terminus of Run x factors , suggests , an inherent difficulty in predicting the
transcriptional effect of a given Runx site. This molecular complexity provides the
necessary vers;ltility to accommodate the different biological functions of the broad
spectrum of Runx-regulated genes. Our studies provide the first evidence that Runx2 '
factors in osteoblasts regulate bone tissue-specific transcription not only through their
DNA binding activity, but also as nuclear matrix associated factors that mediate
chromatin organization and facilitate transcriptional activity by association with other
trans activating factors.
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INTRODUCTION
Bone is one of the major physiologic sites for the biological action of 1
dihydroxyvitamin D3, the active form of vitamin D. This steroid hormone regulates
principal events associated with bone formation and resorption. The in vivo effects of
vitamin D are largely mediated by a specific vitamin D receptor (VDR), which belongs
to the steroid and thyroid hormone receptor superfamily (Truss et aI., 1995;
Mangelsdorf and Evans, 1995; Chambon , 1996). VDR is a ligand-dependent
transcription factor that is capable of recognizing and binding to cis-acting vitamin D
responsive elements (VDREs) in the promoter region of target genes to induce or
repress their transcription (Tsai and OMalley, 1994; Darish and DeLuca, 1993).
Osteoca1cin (OC) is a bone-specific protein whose transcription is directly
regulated by vitamin D (Lian et aI. , 1989b; Demay et aI., 1989). Transcriptional
analysis has established a positive cis-acting element, located between nuc1eotides -461
and -445 of the rat osteoca1cin promoter, that confers vitamin D responsiveness (Owen
et aI. , 1990c; Terpening et aI. , 1991; Breen et aI. , 1994). Enhancement of OC
expression in response to vitamin D occurs only after basal tissue-specific transcription
is initiated by bone-specific factors.
Initiation of basal expression , as well as enhancement by vitamin D, of rat
osteoca1cin gene transcription is accompanied by changes in the structural properties 
chromatin (Montecino et aI. , 1994b; Montecino et aI. , 1996b). In proliferating
osteoblasts and cell lines that do not express OC , the promoter is uniformy packed in
nuc1eosomes, which suppress transcription. However, in differentiated osteoblasts
where OC is transcriptionally active, rearangement of chromatin in the promoter
region results in the appearance of two DNase I hypersensitive sites (DHS). These
DHS are localized in two regions of the promoter that contain important transcriptional
elements: the distal site (-600 to -400bp) spans the vitamin D responsive element
(VDRE), two Runx binding sites and a YY1 binding motif, while the proximal site (-
170 to -70bp) includes a Runx element, a C/EBP binding site and a Dlx5/Msx2
homeodomain motif. The presence and intensity of these DHS correlate with levels of
OC transcription. For instance , in the ROS 24/1 cell line, which does not express OC
no DNase I hypersensitivity is detected. However, in confluent cultures of rat
,,.., .
.I-
t''''
;, !:
iiJ
osteoblastic ROS 1712. cells, where OC is transcriptionally active , the presence of two
;::
;l'1-
DHS is detected. Treatment of cultures with vitamin D results in transcriptional
~~~~
induction ofOC and the DHS are significantly intensified (Montecino et aI. , 1994b).
Furthermore, recent studies have shown that the transcriptionally active rat OC gene
rCi:I;b
promoter is associated with acetylated histones H3 and H4 and the acetylation of these
r. ;I
:i:
;'
:Ie:li
: '
;:1"
histones is increased in response to vitamin D (Shen et aI. , 2002). ; !:;;'I;
- :
1ti
It is generally accepted that binding of transcription factors to their cognate
;i;
.;P.
11:.,
elements on a promoter allows the recruitment of coactivators, chromatin remodeling
! ': ::'
complexes and histone modifying enzymes and results in the reorganization of the
"\'\:1
;f!
chromatin necessary for transcriptional activation of a gene (Dynlacht et aI. , 1991;
1::
DiRenzo et aI., 2000; Myers and Kornberg, 2000; Narlikar et aI. , 2002; Kornberg and
Lorch, 1999; Cheung et aI. , 2000; Berger, 2002). In this study we have addressed the
role of vitamin D receptor interaction with the rat osteocalcin VDRE in mediating the
chromatin modifications required for OC expression. This VDRE is a multiparite
element with recognition sequences for the transcription factors YY1 and AP-
parially overlapping the steroid half elements (Owen et aI., 1990b; Guo et aI., 1997).
Previous studies have shown that forced expression of YY1 decreases vitamin D
dependent enhancer activity of the OC gene in a dose dependent manner (Guo et aI.
1997) and mutation of the AP- 1 binding site severely inhibited vitamin D
responsiveness (Ozonoet aI., 1990). Liganded VDRlXR can interact withand
recruits to the target gene promoter coactivators such as p300, SRC- 1, a member of
p160 family that possesses,HAT activity, and DRIP, a protein complex that helps the
transcription machinery to contend with the nuc1eosome structure in an , nntilnow
'- ';
undefined way (Rachez ef aI. , 1999; Freedman , 1999). The paricular coregulatory
: (il' 
proteins recruited by VDR may contribute to the specificity of OC transcriptional
regulation. Our results demonstrate that mutation of the VDRE results in increased
basal activity bf the OC gene, although formation of basal DNase I hypersensitivity is
not altered. In CQntrast, transcriptional upregulation and increased accessibility of
... ,::'
:1:
DNase I in response to vitamin D require an intact VDRE motif. We also find that
chromatin remodeling of the proximal OC promoter is altered in the VDRE mutant
;i.
(mSHE). Thus binding VDR/R is determinant to assure a tight control of OC
expression and to fine-tune the chromatin changes required for OC ,expression.
,f?:'
RESULTS
Mutation Of The Vitamin D Responsive EJement (VDRE) ResuJts In Increased
BasaJ TranscriptionaJ Activity Of The OC Promoter
In order to assess the contribution of the VDRE in regulating native OC
promoter activity and its potential role in the chromatin remodeling that accompanies
OC gene expression , we established a series of monoclonal stable cell lines of rat
osteoblastic ROS 17/2.8 cells. These cells harbor a 1.1Kb OC promoter with point
mutations in each of the two Steroid Half Elements of the VDRE (mSHE)(Fig. 4. 1), or
in the three Runx binding sites (mABC). Although both YY1 and AP- 1 binding sites
partially overlap the VDRE, the introduced mutations abolish VDR binding but they do
not affect binding of AP- 1 or YY1 to their respective binding motifs (Aslam et aI.
1999) .
The effects of these mutations on OC promoter basal activity were first
analyzed by transient transfection in ROS 24/1 cells, which do not express the VDR
(Baran et aI., 1991). No significant difference could be observed in these cells between
the wild type and mutant OC promoters (Fig. 4.2A). However, significant differences
in promoter activity were noted in ROS 17/2.8 cells, which represent a mature
osteoblast phenotype and express the VDR as well as the endogenous OC gene. The
basal activity of the SHE mutant was higher (2.5x) than wild type, and mABC was
lower (4x) as noted previously (Fig. 4.2B, see also chapter 3). Similar differences in
basal activity were observed in monoclonal stable cell lines carrying either the wild
type or the mutated promoters (Fig. 4.2C). These results suggest that basal levels of
OC transcription are influenced by VDR binding.
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Figure 4.2 Basal activity of wild- type and mutated DC promoters: Basal activity
of plasmids carrying wild-type or mutated OC promoters was assayed by transient
transfection in ROS 24/1 (A) or ROS 17/2.8 cells (B) (n=12). Cells were transfected
with 1 ug of promoter-reporter construct using SuperFect transfection reagent
(Qiagen , Inc. , CA). pGEM is an empty vector used as control. Cells were treated with
1O- M 1,25(OH)2 and harvested 24 h post- transfection to determine CAT activity.
Panel (C) average basal activity of five independent monoclonal cell1ines carring the
indicated OC- smid
We next tested the ability of vitamin D to induce promoter activity of the stable cell
lines (Fig. 4.3). Monoclonal cell lines carying the mSHE-CA T trans gene completely
lack responsiveness to vitamin D , confirmng the loss of VDR-DNA interaction. A
similar loss of responsiveness was also observed with cell lines carying the mABC
trans gene (where all Runx binding sites are mutated) as previously reported (Javed et
aI. , 1999). In contrast, cell lines harboring the wild-type trans gene showed a 4-'5-f61d
increase in promoter activity upon treatment with vitamin D (Fig 4.3A). For
comparison, the effectiveness of vitamin D treatment on the activity of the endogenous
DC gene in these cell lines was assessed by measuring secreted osteoca1cin levels (Fig.
3B). All cell lines presented a 3- fold induction of DC in response to vitamin D.
;.1-
Thus these data suggest that all cell lines maintain their osteoblastic phenotype and that :f:
the loss of vitamin D responsiveness by mSHE and mAC is due to mutation in the
promoter.
The observation that mutation of Runx binding sites abolishes vitamin D
:!(:::: :,,
responsiveness prompted us to test the effect of VDRE mutation on Runx2 dependent
"!t:
activation of the DC promoter (Fig. 4.4). For these experiments we used HeLa cells
because they do not express Runx2 (see Fig. 5.6A) and lack any Runx DNA binding
j. 
activity (Armesila et aI., 1996). As shown in figure 4.4 , VDRE mutation did not
abolish Runx2 activation of the DC promoter. In contrast , Runx2 activation of mSHE
was significantly higher (25 fold) than wild type (10 fold). Also , the expected loss of
Runx2 induction was seen for the mABC promoter. Thus, these findings demonstrate
that mutation of the VDRE motif increases basal and Runx stimulated expression of the
DC promoter.
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Figure 4.3 Vitamin D responsiveness of stable cell lines: (A) Loss of vitamin D
responsiveness of the rat OC promoter with mutation either in VDRE (mSHE) or in the
three Runx binding sites (mABC). Five independent ce)) lines for each transgene were
treated 3 days after plating with 1O- M 1 25(OH)2 and assayed 24 h later for CAT
activity. The CAT values were normalized to total protein in the cell lysate. Each bar
represents the mean value of at least three independent determinations for each cell line.
(B) The levels of secreted OC in the culture media were measured by RIA. The values
are plotted as fold induction (Vitamin D/Control).
(I'
Figure 4.4 Runx2-mediated activation of mutated OC promoters in HeLa cells:
The Runx2 expression construct (0.4 J.g) and the indicated OC-CA T plasmids (1/lg)
were co-transfected into HeLa cells and assayed 24 h after transfection. CA T activity
was calculated as percent conversion and normalized for luciferase values used as
internal control (n=9). The values are plotted as fold induction (Overexpressed
Runx2/Control).
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Basal DNase I Hypersensitivity Of The OC Promoter Is Unaffected By Mutation
Of The VDRE
Previous studies from our laboratory have shown the presence of DNase I-
hypersensitive sites in the endogenous OC gene and in trans genes of stable cell lines
with an integrated OC promoter (Montecino et aI. , 1996a). As noted earlier, this
hypersensitivity was absent in stable cell lines carying the mABC plasmid that harbors
mutations in all three Runx sites (Fig. 4.5; see also chapter 3). Because the distal
hypersensitive site (DHS II) encompasses the VDRE and vitamin D induction of OC
transcriptional activity results in an increased DNase I accessibility ofthe OC promoter
we examined the effect of the VDRE mutation on nuclease hypersensitivity during
basal and vitamin D-induced transcription. Figure 4.5 top panel shows theresults of
DNase I digestion of nuclei isolated from the ROS 17/2.8 cell line carrying the mSHE
plasmid. The two DNase I hypersensitive sites are present both in the control cells and
in cellstreated with vitamin D. However, a decrease in nuclease accessibility,
especially at the distal DHS , was observed after vitamin D treatment (Fig. 4.5 top right
panel). The responsiveness of these cell lines to vitamin D treatment was confirmed by
analyzing the DNaseI digestion profie of the endogenous OC gene. As expected , the
nuclease accessibility of the endogenous gene was increased by vitamin D treatment
(Fig. 4.5 middle panel). The lower panel in figure 4.5 shows the DNase I profie of a
monoclonal stable cell line carying the mAC plasmid, as it has been previously
described (Fig. 3.8) no DNase I hypersensitive sites were present in the mutant
promoter. Taken together these results demonstrate that appearance of the two DHS
DN ase I
Transgene
mSHE
Endogenous
Transgene
mABC
1 3 5 0 1 3 5 Vlml
7 Kb
DHS II
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Figure 4.5 DNase I-hypersensitivity profie of the endogenous OC gene and OC CA T
transgenes: Nuclei isolated from untreated (control) or vitamin D treated (10- vitamin
25(OH)2 for 24 h) ROS 17/2. monoclonal stable cell lines were incubated with
increasing amounts of DNase I for 10 min at room temperature. The DNase I
concentrations (U/ml) are designated above each lane of the Southern blot. The DNA was
then purified and digested with XbaI to detect the trans gene or BamHI to detect the
endogenous gene. All samples (10/lg) were resolved on a 1.2% agarose gel, transferred to
a Hybond N+ membrane and hybridized with the corresponding probe. The two DNase I
hypersensitive sites (DHS I and DHS II) are indicated by the solid arrows.
associated with initial chromatin remodeling during OC gene activation is independent
of VDR interaction.
Mutation Of VDRE And Runx Elements Alters The Chromatin Structure Of The
OC Promoter
We next examined accessibility of the mutated promoters to restriction
endonuc1eases , as an indication of modifications in nucleosome positioning during,
basal and vitamin D induced states of OC gene expression. We selected restriction sites
in the proximal and distal promoter regions, which undergo extensive remodeling
l :;I
during both OC gene activation and vitamin D mediated enhancement (Montecino et
',:
aI. , 1996b). The digestions were performed on nuclei isolated from ROS 17/2.8 stable
cell lines carying mSHE (VDRE) and mABC (Runx) transgenes. As shown in figure
, the endogenous OC gene is highly accessible to all the restriction enzymes tested
and vitamin D treatment results in an enhanced cleavage by Pst!, PvuH and HincH. The
, JL
percent digestion by each enzyme and changes mediated by vitamin D treatment are
'1..
summarized in Table 4. 1. Although the overall pattern of restriction accessibility seen
for the mSHE trans gene is similar to that of the endogenous OC gene (Fig. 4.6A, 4.
""I
Table 4. 1), the percent of digestion by PstI, PvuH, and BglII is substantially lower than
for the wild-type promoter. Interestingly, the changes are restricted to this region only,
as the level of HincH digestion is essentially the same in the wild type and the VDRE
mutant promoter (Table 4. 1). However, in contrast to the wild type OC promoter, the
mutated trans gene shows no change in restriction cleavage upon vitamin D treatment
consistent with the loss of vitamin D responsiveness (Fig. 4.3A).
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Figure 4. Restriction enzyme digestion of endogenous and mutated 
promoters: (A) Restrction digestion profie of endogenous OC promoter from
mSHE cell line. ROS 17/2.8 monoclonal stable cell lines were treated with vitamin
D for 24 h. Nuclei were isolated and digested with different restriction enzymes for
30 min at C. Purified DNA (10 /lg) was digested BamHI to analyze the
endogenous OC gene, fractionated electrophoretically in a 1.2% agarose gel
transferred to Hybond N+ membrane and hybridized with a BamHI-HindIII probe.
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Figure 4.6 Restriction enzyme digestion of endogenous and mutated OC promoters:
(B) Restriction digestion profie of the mSHE transgene. ROS 17/2.8 monoclonal stable
cell lines were treated with vitamin D for 24 h. Nuclei were isolated and digested with
different restriction enzymes for 30 min at 37 C. Purified DNA (10 /lg) was digestedXbaI to analyze the transgene, fractionated electrophoretically in a 1.2% agarose gel
transferred to Hybond N+ membrane and hybridized with a Xba I-Nco I.
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Figure 4.6 Restriction enzyme digestion of endogenous and mutated OC promoters:
(C) Restriction digestion profie of mABC transgene. Nuclei were isolated and digested
with different restriction enzymes for 30 min at 37 C. Purified DNA (10 Jlg) was
digested XbaI to analyze the transgene, fractionated electrophoretically in a 1.2% agarose
gel, transferred to Hybond N+ membrane and hybridized with a Xba I-Nco I.
TABLE 4.
PERCENT OF RESTRICTION ENZYME
DIGESTION
Hine II Pvu IIBgI II
Probe 1:L
,. .
Pst I
; ,;:
Hine II Bgi II Pvu II a Pvu II b Pst I Pvu II c
Cell Line
",'
531 346 282 151 148 +168
28:t1.4 55:t3 66:t3. 67:t2
(Endogenous) 50:t0. 56:t2. 79:t4 76:t1
mABC 9:t0. 31:t0. 8:t0. 18:t1. 12:t.
11:t1 31:t1.5 7:t0. 18:t0. 21:t2 12:t1
mSHE 33:t2. 40:t2. 12:t0. 3 O:t 1 1.2
!'j.,
28:t0. 7 37:t0. 11:t0. 33:t1.4 45:t2
,..
nd: no determned
na: no appicable
Restriction enzyme accessibilty of wild type and endogenous promoters was assay in
three different monoclonal cell lines for each promoter. Digestion product were analyzed
by Southern blots (Fig 4.6), quantitated by PhosphoImager analysis and expressed as
Percent Digestion (100*product/(product + substrate)).
The mABC Runx mutant transgene showed nearly complete loss of cleavage by HincH
(9%) and a significantly decreased accessibility to Pst! (22% vs 67%) (Fig. 4.6C, Table
1). There were no changes in restriction enzyme accessibility upon treatment with
vitamin D. These observations are consistent with the low basal promoter activity as
well as the lack of vitamin D responsiveness of the OC promoter in the mABC cell
lines' (Fig. 4.2C, 4.3A). Notably the cleavage pattern observed for the mABC trans gene
partially resembles the digestion pattern obtained for the transcriptionally inactive OC
promoter (Montecino et aI. , 1996b).
Taken together with the transcription results , these data support the concept that Ii;
chromatin remodeling at the distal (HincH site) and proximal (Pst! site) promoter
regions are required for maximal OC expression and that Runx sites are essential for
chromatin remodeling of the OC promoter. Moreover, the decreased accessibility of
the mSHE OC promoter downstream of the VDRE motif but normal levels of digestion :F.
upstream of it suggests that at least two independent chromatin remodeling processes
occur at the OC promoter. One of them is dependent of Runx2 binding and results in
formation of the two DHS observed in the active OC promoter, as well as a general
increase in accessibility of the OC promoter region. The second event is related to
VDR binding, and has as a consequence an increased opening of the chromatin towards
the transcription initiation site.
Histone H3 Acetylation At The OC Promoter Is Increased By Mutation Of The
VDRE But Unaffected By Runx Mutation
Remodeling of chromatin structure at the OC promoter in response to vitamin D
is accompanied by increased acetylation of both histone H3 and H4 (Shen et aI. , 2002).
In order to investigate histone modifications during recruitment of Runx2 and VDR to
the OC promoter, we performed chromatin immunoprecipitation (ChIP) using
antibodies that detect acetylated histones H3 and H4.. To distinguish the endogenous'
OC promoter from the transgene , we designed primers with 3' nucleotides carying
either the wild type or the mutated sequences (Table 4.2). These primers were first'
tested for their ability to selectively amplify the mutant versus the wild type gene. As
shown (Fig. 4.7, right panel), under the PCR conditions used each set of primers
amplified selectively the respective promoter.
We then proceeded to evaluate the acetylation status of the histones associated
with each of these promoters. We find acetylation of both H3 and H4 at the
endogenous OC locus as previously reported (Shen et aI. , 2002). Acetylation levels for
histones H3 and H4 at the transgene carrying mutated Runx binding sites (mABC) and
acetylation levels for histone H4 at the mSHE transgene are comparable to the levels at
the endogenous OC locus (Fig. 4.7). However, acetylated H3levels at the SHE mutant.
promoter are higher than the wild type. It has been shown that in vitro, histone
acetylases (HATs) exhibit a differential specificity for the four histones (Roth et aI.
2001); therefore our results suggest that different HAT activities are recruited at the
wild type and the mSHE promoter under conditions of basal expression,
Vitamin D treatment results in increased acetylation of bothH3 and H4 at the
endogenous OC locus (Shen et aI. , 2002). However, no significant changes in
acetylation were observed at either of the trans gene promoters in response to vitamin D
(Fig. 4.7). These data are consistent with the loss of vitamin D response for
transcription, DNase I and restriction enzyme accessibility exhibited by the mSHE and
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Figure 4.7 Association of acetylated Histone H3, H4 and RNA polymerase II with
endogenous and mutated OC promoters: Chromatin immunoprecipitation assays were
petfonned with fonnaldehyde-crosslinked chromatin isolated from control or vitamin D
treated monoclonal ROS 17/2.8 stable cell lines. The antibodies used were against either
acetylated H3 and acetylated H4 or RNA polymerase II. (A) Representative
autoradiographs of PCR products obtained from the chromatin immunoprecipated with
the indicated antibodies. The right panel (plasmids) shows the specificity of primers in
selective amplification of wild-type versus mutant plasmid ( no PCR). ' (B) Data in A
were quantitated by PhosphoImager analysis and nonnalized vs. input levels (n=5).
TABLE 4.
PRIMERS USED FOR PCR REACTIONS
Oligonucletide Sequence 5' - 3 ' T Ann. (O
AwtF
( -
619) GCTCTCCCCCA TCAAAACC (-620)
AmP 619) GCTCTCCCCCATCAAAAAG (-602)
BwtR 421) AAACCCCAAGAAGGAGCGG (-439)
BmR 421) AAACCCCAAGAAGGAGCAA (-439)
VDRE. 475) AGCTGCCCTGCACTGGG (-459)
SHE. 476) GAGCTGCCCTGCACTGTA (-459)
OC. 319) CATAGCCTAGAGAGGGTACA (-338)
CwtF 141) GTCACCAACCACAGCATCCTTTG (- 119)
LMOC. (+20) AGCAGAGAGAGGGTCCTCATG (-
LMCAT. (+45) TAGCTCCTGAAAATCTCGCCAAG (+23)
rMYOG Fl (28) CGACCTGATGGAGCTGTATG (47)
rMYOG R (201) GGACAATGCTCAGGGGTCC (220)
r/'
mAC promoters. Taken together our results for DNase I and restriction enzyme
accessibility confirm that no changes in chromatin organization of the OC promoter are
produced in response to vitamn D treatment when either the VDRE (mSHE) or all the
Runx binding sites (mAC) are mutated.
We also compared histone modifications at the myogen in locus, a muscle
specific gene , as a prototype for a gene that is inactive in osteoblastic ROS 17/2.8 cells.
Acetylation of H3 or H4 was not observed at this locus indicating the silent state of the
myogenin gene in osteoblasts (Fig. 4.7).
To confirm that wild type and mutated OC promoters are transcriptionally
active , we performed ChIP assays using antibodies specific to hyperphosphorylated i: 
RNA polymerase II (RNA pol II), which recognizes the active (elongating) form of the
polymerase. Our results show that RNA pol II is present on both the wild type and the
mutant promoters; however, the levels are significantly higher on the SHE mutant
promoter. Thus the high basal level of transcriptional activity observed for the SHE ;I;!;i 1:1
promoter (Fig. 4.2B, 4.2C) is well correlated with the levels of pol II detected at the
promoter. Interestingly, a significant increase in pol II recruitment upon treatment with
vitamin D was observed only for the wild-type promoter. Taken together, the levels of
H3-H4 acetylation and recruitment of pol II are reflective of the activities of the wild
type and mutant promoters either in basal or vitamin D induced conditions.
DISCUSSION
The vitamin D element in the bone tissue-specific osteocalcin gene has served
as a prototype for understanding molecular mechanisms regulating physiologic
responsiveness of vitamin D-dependent genes in bone cells. Vitamin D promotes
cellular differentiation and the significant upregulation of OC transcription, a marker of
the mature osteoblast phenotype, reflects this physiological effect on osteoblasts
maturation. Vitamin D enhanced activity of the OC gene is tightly regulated to ensure
physiological levels of OC in bone cells.
In this study, we found that mutation of the VDRE (mSHE) results in an
increased basal activity of the rat OC promoter accompanied by complete loss of
vitamin D responsiveness. As mentioned earlier, the rat OC VDRE contains an internal
:':'
r;;ii
AP- 1 and a partially overlapping YY1 element. Previous studies from our group have
shown that in proliferating osteoblasts , high expression levels of c-fos and c-jun
contribute to suppression of the OC promoter; while in differentiated osteoblasts , fra2
and junB accounted for high levels of OC expression. Moreover, mutation of the AP- :; J'
'I.
;:;!
binding element severely inhibits vitamin D response suggesting a possible interaction ii'
between AP- 1 and VDR/R to facilitate enhancer activity (McCabe et aI., 1996;
Aslam et aI., 1999). In vitro analysis of the SHE mutant demonstrated that AP-
_"-
Il..
binding is not affected (Aslam et aI., 1999). It is possible , however, that in vivo the
\\,
absence of VDR binding results in an enhanced binding of AP- 1 family members to the
"..
OC promoter. On the other hand, the YY1 binding site partially overlap VDRE and 1-:
forced expression of YY1 decreased vitamin D enhanced transcription, suggesting that
YY1 competes with VDR for OC binding (Guo et aI. , 1997). Recently it has been
shown that over-expression of YY 1 in the absence of vitamin D induction results in
increased OC expression (Montecino personal communication). Therefore mutation 
the VDRE may result in YY1 binding and increased promoter activity. An alternative
explanation for these results is based on the observation that many nuclear receptors
activate gene expression in response to ligand binding and repress gene expreSsion in
its absence (Xu et aI., 1999; Torchia et aI. , 1998; Nagy et aI. , 1997; Heinzel et aI.,
1997). Therefore it is possible that mutation of the VDRE abolishes binding of 
unliganded VDR to the OC promoter resulting in an increased basal activity as well as a
concomitant loss of vitamin D induction.
Ligand binding to nuclear receptors induces a series of conformational changes'
that allow the formation of dimers and recruitment of co-activator complexes (Glass
and Rosenfeld, 2000; Xu et aI. , 1999; Darimont et aI., 1998). Until now , two distinct
i:i
;11'
classes of nuclear receptor co-activator complexes have been identified. One class
::,
contains co-activators that are proposed to act by altering chromatin structure and
includes complexes with histone acetyl transferase activity; such as CBP/p300 and 11:,
p160 (SRC- 1fTIF2/AIBl) family proteins (Kamei et aI., 1996; Ogryzko et aI. , 1996;,
Onate et al. , 1995; Voegel et al., 1998; Anzick et aI., 1997; HeInzel et aI., 1997) and the
;! 
ATP-dependent chromatin remodeling complex SWI/SNF (Ostlund Farants et aI.
1997; Ichinose et aI. , 1997; Fryer and Archer, 1998). The second class corresponds to a
o-activator complex, DRIPfTRAP/ARC (Fondell et at; 1996; Gu et aI. , 1999; Ito et
- \
.;;i 
aI., 1999; Rachez et aI. , 1999), without known chromatin remodeling activity; it is "1:1
i: i
worth noting that many components of this complex are also present in a mamalian
!;:';"':
complex that corresponds to the yeast transcriptional mediator complex (Gu et aI.
1",,
j
1999).
Analysis of the chromatin structure in stable cell lines carying the mSHE OC
promoter demonstrates that both of the DNase I hypersensitive sites identified in the
endogenous OC promoter are present under basal conditions. However, treatment with
vitamin D results in a decreased hypersensitivity, especially at the distal DHS that
correlates with the decrease in transcriptional activity observed upon vitamin D
treatment of the mSHE cell line. Interestingly a competition model has been proposed
to explain the antagonism observed between AP- 1 and VDR in genes that contain
binding sites for only one of these factors (Kamei et aI. , 1996). According to this
model, limiting amounts of CBP/p300 or general transcription factors are paritioned by
the alternative activation of VDR by ligand or of AP- 1 by phosphorylation. It is
possible then that activation of VDR results in a loss of co-activators from the OC
promoter when the VDRE is mutated.
As has been previously published (Javed et aI. , 1999) an OCpromoter carying
mutations in all Runx sites (mABC) does not respond to vitamin D treatment and does
not exhibit DNase I hypersensitivity. In the present work, we show that the
accessibility of the mABC promoter to restriction enzymes is dramatically reduced
resembling the digestion pattern obtained when the gene is inactive (Montecino et aI.
1996b). In contrast , stable cell lines carrying the mSHE promoter show a significantly
decreased accessibility only in restriction sites located downstream of the VDRE.
However, except for acetylated H3 that is increased at the mSHE promoter, histone
acetylation levels are similar in mutated and wild type promoters. These results suggest
that a different mechanism of chromatin remodeling is responsible for the changes in
DNA accessibility.
Taken together our results indicate that the chromatin remodeling of OC
promoter required for its full activity and hormonal responsiveness is a complex
process that involves multiple steps and probably the recruitment of different co-
activators either simultaneously or in a sequential fashion. Future studies should aim to
determine the sequential order of events required for the re-arangement of chromatin at
the OC locus once this gene star to being expressed during osteoblast differentiation.
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INTRODUCTION
The CCAAT/ enhancer-binding proteins (C/EBPs) comprise a family of
transcription factors that are critical for normal cellular differentiation and metabolic
functions in a variety of tissues. There are currently six members of the C/EBP family
designated as C/EBPa , 8, y, E and t; (Lekstrom- Himes and Xanthopoulos, 1998)
most of which are expressed in liver, spleen and adipocytic tissues. However, more
selective expression in other tissues has been observed among the family members
:!i
(Alam et aI., 1992; Antonson and Xanthopoulos , 1995; Birkenmeier et al. , 1989;
' ,
Morosetti et aI. , 1997; Wang et aI. , 1995; Yamanaka et aI. , 1997). Isoforms of the
C/EBP proteins are known and all function byhomo- or heterodimerization with one
another and interaction with other transcriptional activators or co-activators such as NF-
, Stat3 , c-Myb , PU. , SP- , ATF- , PPARy and Runxl (Lopez-Rodriguez et aI. i::!'
f::!
1997; Oelgeschlager et aI. , 1996; Shuman et aI. , 1997; Spiegelman et al. , 2000; Stein
and Lian , 1993; Zhang et aI. , 1996a; Zhang et aI., 1996b).
Very little is known about the role of C/EBP factors in osteogenesis. Targeted
",":j:
disruptions of C/EBP genes have been performed , but in none of the studies were gross
,' 
:l :.
,::
abnormalities of the skeleton observed (Wang et aI. , 1995; Tanaka et aI., 1995;
;
Sterneck et aI. , 1997; Tanaka et aI. , 1997). However, recent studies have identified jli
lfl
C/EBP regulation of genes expressed in osteoblasts, The insulin-like growth factor 1
(IGF- l) is a key regulator of osteoblast growth and differentiation (Gabbitas and
Canalis, 1998). C/EBP8 enhances either basal or prostaglandin E2-activated
transcription of the insulin-like growth factor I promoter in osteoblasts (Umayahara et
aI., 1997; Harison et aI., 2000). Expression ofCOX-2 and the a1 subunit of Type I
collagen are also regulated in osteoblasts by C/EBP factors (Attard et al., 2000;
Ogasawara et aI. , 2001). The interaction of C/EBPa with a Runx1 factor (Petrovick et
aI. , 1998) is also particularly relevant for postulating a role for C/EBP factors in
osteoblast differentiation.
The Runt related transcription factors (Runx/ AML/CBFaJEBP2a) represent
essential gene regulatory proteins that control lineage commtment for hematopoiesis
(Okuda et aI. , 1996; Speck et aI. , 1999; Wang et aI. , 1996) and osteogenesis (Komori et
al. , 1997; Mundlos et aI. , 1997). Runx2 (AML3/Cbfa1/PEBP2aA) is the most abundant
ii:
Runt related protein in osteogenic and chondrogenic cell lineages (Banerjee et aI.
1997; Ducy et aI. , 1997; Javed et aI. , 2001). Genetic ablation of the Runx2 gene causes i:fj
; ,',
developmental defects in osteogenesis (Komori et aI. , 1997) and hereditary mutations in
the Runx2 gene are linked to specific ossification defects as observed in cleidocranial
dysplasia (Otto et al. , 1997). Runx2 is essential for osteoblast differentiation (Banerjee
::1et aI., 1997; Ducy et aI. , 1997; Komori et aI. , 1997) and regulates expression of
numerous bone-related genes (Banerjee et aI. , 1997; Jimenez et al. , 1999; Javed et aI.
2001; Ji et aI. , 1998; Sato et aI. , 1998). The importance of Runx2 in expression of the
'"., \
bone-specific osteoca1cin (OC) gene is well documented (Javed et aI. , 1999; Frendo et :IdIITf
H'l
!
IIII
aI. , 1998). Thus Runx2 performs specialized functions during bone-tissue development
and differentiation in vivo. However, it is noteworthy that osteoblast-specific
scription of osteoca1cin occurs even in the absence of Runx sites in the rat OC
promoter (Hoffmann et aI. , 1996), suggesting a tissue-specific role for other regulatory
factors in osteoblasts.
Activation of tissue specific genes is controlled by combinatorial mechanisms
that rely on local features of the promoters , including organization of control elements
in the target genes and/or the interplay between DNA binding proteins and various
transcriptional co-regulators (Graves, 1998). Both C/EBP and Runx factors have been
shown to cooperate with chromatin remodeling factors (p300, SWI/SNF) and other
enhancer-binding proteins (Kitabayashi et aI. , 1998; Kowenz-Leutz and Leutz , 1999).
For example, Ets- , c-Myb, Sp1 and C/EBP, together with Runx factors, stimulate the
transcription of hematopoietic and osteogenic genes (Petrovick et al., 1998; Sun et al.
1995; Zaiman and Lenz, 1996; Zhang et aI. , 1996a; Zhang et aI. , 1996b; Gu et aI.
2000) while PP ARy and Stat3 interactions with C/EBPa are driving forces for !I.
il 
adipocyte differentiation (Rosen et aI. , 2000). Given these observations, i. , the i!!lili1I1
presence of both C/EBP and 8 and Runx2 in osteoblasts (McCarhy et aI., 2000; I!:.I
:i ;::!
Banerjee et aI. , 1997; Ducy et al. , 1997) and C/EBPa-Runx1 protein-protein
interactions in regulation of a hematopoietic specific gene (Zhang et aI. , 1996a), we ilm!t
addressed the possible role of C/EBP factors in osteoblasts and in the regulation of a
bone specific gene , osteoca1cin.
Here we report that C/EBP and 8, but not a are developmentally expressed
during osteoblast differentiation and are upregulated in response to 1 25(OH)2 , a :1 
i! :I;!!I
hormone that promotes osteoblast differentiation. We have identified a C/EBP
:;iIW:
HII,!!il:
responsive regulatory element in the proximal promoter of the bone specific osteoca1cin
gene. Deletion or mutation of this motif abrogates transcriptional enhancement by
C/EBP factors. Furthermore, we provide the first demonstration that Runx2 and
C/EBP physically interact and that C/EBP and Runx proteins act synergistically to
:,;
:'i
activate the OC promoter. hnportantly, this functional synergism is mediated lhrough
the C/EBP element. These findings establish for the first time a role of C/EBP in the
regulation of an osteoblast specific gene and define a novel mechanism for C/EBP in
the regulation of cell type specific gene transcription.
RESULTS
C/EBP Family Members Are Expressed During Osteoblast Differentiation And
Are Regulated By Vitamin D3
We initially assessed the expression of C/EBP factors in various bone tissues
and during development of the osteoblast phenotype. Figure 5. 1A shows that C/EBP p
and 0 mRAs are present in calvarial tissue (lane 2) at levels similar to those in a
representative soft tissue, muscle (lane 1). C/EBP ex is not detected in bone tissue,
consistent with its pivotal role for adipogenesis. Osteoblast markers (OC, Runx) that
are not present in soft tissues are shown for comparison. The abundance of C/EBP p
and 0 in bone prompted examination of expression of the C/EBP family members from
growth to differentiation stages of osteoblasts in vitro representing proliferation (days
5), matrix maturation (days 7- 12), and the mineralization stage (days 19-22),
reflected by peak levels of histone H4 , alkaline phosphatase (ALP) and osteoca1cin
(OC), respectively (Fig. 5. 1B).
Both C/EBP P and 0 mRNAs are detected from the growth to maturation stages
and are expressed in a bi-phasic pattern. In contrast, C/EBP ex expression is not
detected at any stage of osteoblast differentiation , consistent with its absence in bone
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Figure 5.1 Bi-phasic expression and vitamin D reguJation of CIEBP transcription
factors during rat osteobJast differentiation and presence in bone tissues: (A) Total
RNA was isolated from various skeletal and soft rat tissues as described in Methods.
RNA (10 !-g) was resolved in a 1 formaldehyde gel and transferred to nylon
membrane. The blots were hybridized with NcoI fragment for C/EBPa, EcoRI-XhoI
fragment for C/EBPp, BamHI-EcoRI fragment for C/EBPo, EcoRI fragment for alkaline
phosphatase , HindII-XbaI fragment for histone H4 , BamHI-XhoI fragment for Runx2
EcoRI-HindllI fragment for GAPDH, and EcoRI-Bamil fragment for the detection of
rat OC. C/EBPp and 0 mRNAs are expressed in both soft and skeletal tissues. Lane 1
muscle and lane 2, day 21 fetal calvaria. (B) Primary rat osteoblasts were 
cultured for
the indicated time (days) and total RNA (10 !-g) was resolved in a 1 % agarose gel and
probed with the above mentioned cDNA fragments. The relative positions of 285
, 185
and 55 ribosomal RNA are indicated for reference.
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Figure 5.1 Bj-phasic expression and vjtanrn D regulation of CIEBP transcriptjon
factors during rat osteoblast differentiation and presence in bone tissues: (A) Total
RNA was isolated from various skeletal and soft rat tissues as described in Methods.
RNA (10 !-g) was resolved in a 1 formaldehyde gel and transferred to nylon
membrane. The blots were hybridized with NcoI fragment for C/EBPa, EcoRI-XhoI
fragment for C/EBP , BamHI-EcoRI fragment for C/EBP3, EcoRI fragment for alkaline
phosphatase, HindII-XbaI fragment for histone H4 , BamHI-XhoI fragment for Runx2
EcoRI-HindllI fragment for GAPDH, and EcoRI-BamHI fragment for the detection of
rat Oc. C/EBP and 3 mRNAs are expressed in both soft and skeletal tissues. Lane 1,
muscle and lane 2, day 21 fetal calvaria. (B) Primary rat osteoblasts were cultured for
the indicated time (days) and total RNA (10 !-g) was resolved in a 1 % agarose gel and
probed with the above mentioned cDNA fragments. The relative positions of 28S, 18S
and 5S ribosomal RNA are indicated for reference.
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Figure 5.1 Bi-phasic expression and vitamin D regulation of CIEBP
transcription factors during rat osteoblast differentiation and presence in
bone tissues: (C) Enhancement of C/EBP factors by vitamin D during
osteoblast differentiation. Primary rat calvarial osteoblasts were cultured in vitro
and collected at three stages of development: proliferation (day 7), matrix
maturation (day 12) and mineralization (day 19). Cells were treated with 10-
vitamin D3 for 24 hours prior to harvesting. Total RNA was isolated as
described in Methods. The Northern blotting and probing were performed
essentially as described in chapter 2. GAPDH is shown as control for loading of
RNA.
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tissue. Two sizes of C/EBP mRA are present with the larger species appearing
more constitutive , while the smaller transcript is expressed during the growth period
(days 3-5). The latter transcript is decreased markedly during the matrix maturation
stage (dayS 7- , when alkaline phosphatase positive cells are forming nodules),
followed by a 4-5 fold increase in expression concomitant with mineral deposition and
peak levels of osteoca1cin and Runx2 expression (Fig. 5. 1B). C/EBP 0 mRNA is
expressed in a similar fashion as C/EBP , but the larger transcript is detected at very
low levels. A significant (5 fold) temporal increase in C/EBP 0 mRA expression is
observed during osteoblast differentiation from confluency (day 7) to the mature
osteoblasts (day 22). Several Runx2 isoforms , which result from utilization of
alternative promoters and differential splicing, are expressed (Fig. 5. 1B). The increase
Iii
III,
I!IIin expression of the major Runx2 transcript during later stages of differentiation is
consistent with increased Runx2 DNA binding activity in mature osteoblasts (Banerjee ! :11
!!fl
et aI. , 1997). Thus , the increases in C/EBP and C/EBP 0 in the late stages of 1111:1 I :1: 
, I"
lfi' lij!i
!1I
II 
i!i::
"'"
, 1!l1I
il:!d
osteoblast differentiation appear to parallel peak expression levels for the osteoblast-
related osteoca1cin gene and the Runx2 transcription factor.
11':i:!!!I':
We further assessed the relationship of C/EBP factors to osteoblast
: Wii;,
ii:i 
11:11
differentiation. Vitamin D3, a hormone that promotes osteoblast differentiation, is a
known enhancer of many osteoblast-related genes (Lian et aI. , 1999a). Expression of
C/EBP is stimulated by vitamin D3 at each stage of osteoblast maturation , 6 fold
during growth (day 7) and nodule development (day 12) and 3 fold during
mineralization (day 19). Vitamin D3 dependent enhancement of C/EBP 0 is similar to
that of C/EBP except the fold stimulation is lower (3 fold at all stages). Treatment of
102
cells with vitamin D3 has no effect on the expression of C/EBP a at any stage 
differentiation. The differentiation:-promoting properties of Vitamin D3 are reflected by
the decrease in histone H4 and the increase in OC expression (Fig. 5. 1C). Thus,
expression of both C/EBP and C/EBP () are strongly enhanced upon treatment with
vitamin D3 in relation to osteoblast differentiation. Taken together these data
demonstrate that C/EBP transcription factors are expressed at significant levels in bone
tissue , increase during osteoblast differentiation in vitro and their expression is
upregulated by 1 25(OHhD
CIEBP Proteins Activate The Osteocalcin Gene Through A CIEBP Responsive
Element In The Proximal Promoter
The enhanced expression of C/EBP and () during mineralization relative to the
onset of OC transcription and in response to vitamin D3 suggests that these C/EBP
!!!
transcription factors may contribute to osteoblast specific expression of the OC gene. iii,
Iii':'
Previous studies using promoter deletion constructs of the rat OC gene have shown that
the initial 200 bp of the promoter can confer tissue specific expression (Hoffmann et
aI. , 1996). This region contains a Runx responsive motif and a homeodomain box that
:r1iI
lili:i; 
also binds an osteoblast specific complex (Hoffmann et aI. , 2000). Sequence analysis
of this region reveals the presence of a C/EBP motif (Fig. 5.2). To determine if the
C/EBP protein(s) can interact with this element, gel mobility shift analyses were
performed using oligonucleotides (see Methods) containing either wild type or mutated
C/EBP binding sequences (Fig. 5.2). Using nuclear extracts from day 20 primary rat
osteoblasts in which OC is actively expressed , we observed two major protein-DNA
complexes (Fig. 5.3). Specificity of these protein-DNA interactions was confirmed by
103
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Figure 5.3 Sequence specific protein-DNA interactions at the rat 
C/EBP element: (A) Oligonucleotides corresponding to wild type or mutated
C/EBP sites from the OC gene were incubated with increasing concentrations
(0- 10 !-g) of nuclear protein from day 20 primary rat osteoblast cultures. (B)
The specificity of the complexes is further demonstrated by competition assays.
Oligonucleotides carrying the wild type C/EBP site from the OC gene were
incubated with 6 !-g of nuclear proteins. The concentration ranges of wild type
or mutant cold competitors are indicated at the top of each lane.
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oligonucleotide competition assays. Addition of unlabeled wild type oligonucleotide
but not mutant oligo, inhibited the binding of the protein complexes to the labeled
probe (Fig. 5.3B). Taken together these results indicate that CIEBP proteins interact in
a sequence specific manner with their cognate element in the proximal promoter of the
bone-specific rat DC gene.
The presence of CIEBP in the protein complex binding to the DC promoter
element suggests transcriptional regulation of the DC gene by CIEBP factors. This
possibility was experimentally addressed by assessing the effect of forced expression of
CIEBP and () on activity of full length (- 1.1kb) and proximal (-208 bp) DC promoter-
CAT reporter gene constructs in the osteoblastic RDS 17/2.8 cell line (Fig. 5.4). The
results indicate that CIEBP and () significantly enhance DC promoter activity, 4-
fold on the full-length promoter (Fig. 5.4A , left panel) and 8 fold on the proximal
promoter segments (Fig. 5.4A, right panel). Western ?lot analysis shows that CIEBP 
and CIEBP () proteins of the expected sizes are expressed (Fig. 5.4B). Thus both
CIEBP and () are potent activators of osteoca1cin gene transcription.
In order to establish that the CIEBP element in the proximal region directly
mediates the enhancement of promoter activity by CIEBPs , site directed mutagenesis
was performed. The CIEBP element in -208 DC-CAT was mutated (see Fig. 5.2) using
the same oligonucleotides used in the gel shift assays. The results show that mutation
of the CIEBP element blocks the CIEBP mediated stimulation (6-8 fold) observed with
the wild type promoter (Fig. 5. 5). Therefore responsiveness of the DC promoter to
CIEBP transcription factors is dependent on the integrity of the CIEBP element in the
basal promoter region.
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Figure 5.4 C/EBP class of transcription factors regulates osteocalcin gene
expression: (A) ROS 17/2.8 cells were transiently co-transfected with 0.75 !lg of
C/EBP or () expression plasmids and 2.5 /-g of - 1 kb OC-CA T (left panel) or -
208 OC-CA T reporter constructs (right panel). Cells were harvested 24 hours post
transfection and CAT activities were determined. The data were normalized to
values for RSV-Iuciferase activity as an internal control. Pooled data from 3
independent experiments are presented as % CAT conversions. Each bar represents
LS:!SEM (n=18). (B) ROS17/2.8 cells plated in 100 mm dishes were transiently
transfected in parallel with 10 !lg of either empty vector or C/EBP and ()
expression constructs. Thirty (30) !lg protein was resolved on 10% SDS-PAGE.
Lamin B antigen is hown as a loading control.
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Figure 5.5 C/EBP mediated activation of the rat OC promoter requires the
integrity of the C/EBP responsive motif: Constructs carrying wild type or
mutated C/EBP elements in the proximal promoter of the rat OC gene (-208 OC-
CAT) or empty vector control (pGEM-CA T) were transiently co-transfected with
C/EBP expression plasmid into ROS 17/2.8 cells. Reporter activities were
determined 24 hours post transfection and normalized to luciferase values used
for transfection control (n=6).
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Functional Synergism Between Runx And CIEBP Proteins Is Mediated Through
The CIEBP Element
Runx2 is a well-characterized regulator of OC gene transcription and a Runx
responsive motif is located in close proximity to the C/EBP element in the proximal OC
promoter. Therefore, functional interaction between these proteins in transcriptional
regulation of the OC gene was tested. For these studies we selected HeLa cells , which
lack Runx2 (Fig. 5.6A) and have no Runx DNA binding activity (Aresila et aI.,
1996). Consistent with these observations, we find low basal activity of the -208 OC
promoter in HeLa cells compared to osteoblastic ROS 17/2. 8 cells (Fig. 5.6B), which
express both C/EBP and Runx2 (Fig. 5.6A). Interestingly, HeLa cells have
significant levels of C/EBP (Fig. 5.6A). Based upon preliminary examination of
dose-dependent effects of Runx2 and C/EBP individually on activity of the -208 OC
promoter, we used a suboptimal concentration of each expression plasmid (0.4 f!g) for
these studies. Expression of either C/EBP 
or Runx2 in HeLa cells stimulates OC
iil
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promoter activity 2-4 fold. However, co-expression of Runx2 and C/EBP results in a
massive activation (30-40 fold) of the OC promoter (Fig. 5.7) demonstrating a
functional synergism between these two proteins. This functional synergy between two
!::I
:;jll
positive regulators of OC transcription is consistent with increased expression of
iJif!:
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i:L
C/EBP and 3, Runx2 and OC during late stages of osteoblast differentiation. 1'"
;:I!!
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To investigate the specific contribution of the Runx and C/EBP elements and
ir cognate factors to synergistic activation of the OC promoter, a series of promoter
constructs bearing mutations in either Runx or C/EBP binding sites were generated
(Fig. 5.8). Each of these constructs was tested for responsiveness to C/EBP and/or
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Figure 5.6 Expression of the rat OC promoter in osseous and non-osseous
cells: (A) Total cellular protein (30 g) from HeLa or ROS 17/2. cells were
resolved on 10% SDS-PAGE. Levels of endogenous C/EBPB and Runx2
proteins were determined by probing the blots with anti-C/EBPB and anti-Runx2
antibodies. Lamin B is shown as loading control. (B) He La or ROS 17/2.8 cells
were transfected with 2 g of -208 OC-CAT constructs. CAT activities were
determined 24 hours post transfection and presented as % CAT conversion.
HeLa ROS17/2;8
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Figure 5. CCAAT Enhancer Binding Protein p (C/EBPP) and Runx2
synergistically activate the osteocalcin promoter: Functional interaction
between C/EBPp and Runx2 was determned by transient co-expression of
C/EBPp and Runx2 constructs (0.4 g each) with 1 g of indicated CAT reporter
along with RSV-luciferase construct (100 ng) into HeLa cells. CAT activities
were determined 24 hours post transfection and normalized to luciferase values.
Data are presented as % CAT conversions (n= 18, from 3 independent
experiments ).
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Figure 5.8 Ilustration of mutations in the proximal OC promoter: Top line
diagram shows the relative positions and sequences of Runx and C/EBP
responsive elements with mutated sequences shown in lower case. Constructs
carring mutation in either Runx or C/EBP elements alone or combined are
indicated.
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Runx2. Data pooled from four independent experiments show a consistent 30-40 fold
synergistic enhancement of the wild type OC promoter by C/EBP and Runx2 (Fig.
9). Mutation of the Runx site did not affect the synergistic response (23-26 fold
enhancement). In contrast, we observed a loss of this functional synergism upon
mutation of the C/EBP motif. A similar loss of synergistic activity was observed when
both C/EBP and Runx sites were mutated (Fig. 5.9). These findings suggest that the
C/EBP regulatory element is required for the synergistic enhancer activity involving
Runx2.
For further insight into the mechanisms involved in Runx2-C/EBP functional
synergism, we tested a series of carboxy termnal deletion mutants of Runx2 (Fig.
5. lOA). Both mutant Runx2 proteins (1-361 and 1-230) are expressed (Fig. 5. lOB),
enter the nucleus (data not shown) and retain DNA binding activity. Figure 5. lOC
shows that both mutants also retain functional activity on the OC promoter but at a
lower level than wild type Runx2. When the mutant Runx2 (1-361) was co-expressed
with either C/EBP or 0, synergistic activation (40-80 fold) of the OC promoter was
observed. However, this synergism did not occur with the mutant Runx2 (1-230).
These Runx mutational studies suggest that a Runx2-C/EBP interaction is required to
'i!
j!!
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support synergistic activation of the OC promoter.
To determine whether functional synergism between Runx2 and C/EBP requires
!il
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a physical interaction , we performed co-immunoprecipitation studies. WT Runx2 and
Runx2 (1-361), which lacks the carboxy terminus , each form a complex with C/EBP
while Runx2 (1-230) fails to interact (Fig. 5. 11). The level ofC/EBP co-
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Figure 5.9 Functional synergism between Runx2 and C/EBP factors is
mediated by a C/EBP- responsive motif in the rat OC promoter: BeLa cells
were transiently co-transfected with 1 Ilg of either wild type or mutated OC
promoter constructs (carring mutation in either C/EBP or Runx sites individually
or together) and 0.4 Ilg of C/EBP or Runx2 expression constructs as indicated.
Reporter activities were determined 24 hours post transfection and normalized to
luciferase values used for transfection control.
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Figure 5.10 Functional synergy between C/EBP and Runx2 requires C/EBP
interacting motif: (A) De)etjon mutants of Runx2 are shown djagrammatjcally.
The runt homology DNA bindjng domain (RHD), nuclear )ocaHza60n (NLS) and
puta6ve C/EBP jnteracting regjon are jndjcated. Pane) (B) shows western blot
ana)ysjs of Xpress-tagged Runx2 protein expressed jn HeLa cells. TubuHn is
shown as a loadjng contro1.
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Figure 5.10 Functional synergy between C/EBP and Runx2 requires CIEBP
interacting motif: (C) Functional synergism is demonstrated in HeLa cells which
were transiently co-transfected with 0.4 !1g each of CMV empty vector, C/EBP
C/EBP8, Runx2 full length and deletion mutant expression plasmid and 1 !-g of
the -208 OC-CAT constructs, as well as 100 ng of a RSV- Iuciferase plasmid.
Cells were harvested 24 hours after transfection and assayed as described in
methods. Data are presented as fold induction (expression constructs/empty
vector control , n=12 from 4 independent experiments).
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Figure 5.11 Co-immunoprecipitation of Runx2 and C/EBPp: Directinteraction between Runx2 and C/EBPP is shown by co-immunoprecipitation.HeLa cells were co-transfected with C/EBPP and the Xpress tagged deletionconstrcts of Runx2 (as indicated) lysed 24 hrs later and immunoprecipitated
with aXpress antibody or mouse IgG as described in methods section.Immunoprecipitated complexes were resolved on 12% SDS-P AGE followed by
western blotting using either aXpressHRP or aC/EBPp.
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immunoprecipitad are very low compare to the total level of protein detected by
western blot in the cell lysate, therefore it is possible that the conditions for
immunoprecipitation are not appropriated to conserve the protein-protein interaction or
that the actual amount of Runx2-C/EBP that interact in vivo is a small fraction of the
total. Due to lack of antibodies that immunoprecipitate the endogenous proteins we
could not determine if this interaction actually occurs in osteoblastic cells.
The absence ofC/EBP in the immunoprecipitated Runx2 (1-230) complex
indicates that amino acids 230-361 of Runx2 are required for this interaction , consistent
with the functional activity data (Fig. 5. lOC). It was previously shown that the runt
homology domain (RHD) of Runx1 support interaction with C/EBP ex (Petrovick et aI.
1998; Zhang et aI. , 1996a). However, our Runx2 deletion analysis reveals that the
RHD of Runx2 is not sufficient for C/EBP interaction (Fig. 5. 11). Our findings are
consistent with the recent co-crystal structure of the RHD with C/EBP (bZIP), which
demonstrates a lack of interaction of these two domains (Tahirov et aI. , 2001). Taken
together our results suggest that the synergism observed on the OC promoter requires
an interaction between Runx2 and C/EBP that involves a region of Runx2 outside the
DNA binding domain.
To establish that the Runx2-C/EBP protein-protein interaction can occur when
!i!)
C/EBP proteins are bound to its regulatory element, we performed gel mobility shift
11111
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assays with the C/EBP motif of the OC promoter (Fig. 5. 12). We compared nuclear
extracts from HeLa cells lacking Runx2 and mature osteoblasts, which contains both
Runx and C/EBP factors (see Fig. 5.6A). We find similar C/EBP complexes formed
with both nuclear extracts; however addition of antibody against Runx2 resulted in
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C/EBP
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Runx2 Ab 
Figure 5.12 Runx2-C/EBP interaction at the C/EBP element: A C/EBP
oligonucleotide (see Fig. 2 legend) was incubated with 10 /Jg of nuclearextracts from HeLa cells (lanes 1 and 2) or day 20 rat osteoblasts (lanes 3 and
4). Nuclear extracts were preincubated with 1 /Jl of Runx2 antibody for 20
minutes at 37 C (lanes 2, 4 and 5). Brackets show C/EBP complexes;
arowhead indicates supershifted band.
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supershift only with the bone cell extracts. These results provide evidence for a
Runx2-C/EBP interaction that is independent of a Runx DNA binding site.
DISCUSSION
Our studies demonstrate that the C/EBP transcription factors support osteoblast
specific gene expression and may play an important regulatory role during osteoblast
differentiation. C/EBP and (), but not C/EBP ex, are expressed in skeletal tissues and
are developmentally regulated during osteoblast maturation. Vitamin D , a positive
regulator of osteoblast differentiation and of the bone-specific osteoca1cin gene , also
increases expression of C/EBP factors. We find that osteoca1cin is a downstream
C/EBP target gene , strongly upregulated in response to forced expression of C/EBP
family members. The level of enhancement is equivalent to that observed for the bone-
related Runx2 transcription factor. More importantly, we also demonstrate that Runx2
and C/EBP and () functionally cooperate for positive regulation of the OC gene and
that the synergism is mediated through a physical interaction between Runx and C/EBP
at the C/EBP element. We propose that C/EBP activity may be physiologically
relevant to the spatio-temporal regulation of Runx2 dependent genes in mature
osteoblasts.
ii'l
Transcription of the OC gene is stringently regulated during osteoblast
Will'
differentiation (Stein and Lian, 1993) but the mechanisms involved have not been
completely elucidated. OC gene induction is coupled to a post-proliferative increase in
Runx2 DNA binding activity (Banerjee et aI. , 1997; Ducy et aI. , 1997). However
Runx proteins are present in skeletal progenitor cells and immature proliferating
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osteoblasts , in which OC gene expression is not activated (Banerjee et aI. , 1997). Thus
other factors are contributing to strong suppression of OC transcription in such cells , as
well as to maximal levels of OC expression in mature osteoblasts. Our studies indicate
that the activities of Runx proteins and transcriptional activation of Runx responsive
genes during skeletal development may be regulated in par by controllng cellular
levels of Runx or C/EBP proteins and/or functional cooperation between Runx and
C/EBP transcription factors. In support of this mechanism are the relative expression
levels of each factor during osteoblast differentiation. Although C/EBP and 0 are
present in proliferating osteoblasts (consistent with their role in cell growth), the low
Runx levels may be insufficient to produce a synergistic effect. In contrast , when the
cellular levels of both factors are elevated during the mineralization stage, synergy may
account for the massive and tissue specific induction of OC gene expression. Notably,
C/EBPo expression is positively regulated by Runx2 (McCarthy et aI., 2000), which
may provide the biological assurance of high C/EBP levels during osteoblast
differentiation when bone specific gene expression is required.
For definitive assessment of the contribution of Runx2 and C/EBP proteins and
their synergistic effect on the OC promoter, we carried out studies not only in bone
cells , but also in HeLa cells which have a zero background for Runx factors (Armesila
et aI. , 1996). Synergistic activation of the OC promoter occurred only when both
mil:factors were expressed in HeLa cells. This situation is analogous to mature osteoblasts
where both proteins are maximally present. Based upon previous observations of the
critical role of the Runx site in maintaining active chromatin conformation of the OC
promoter (Javed et aI. , 1999), we anticipated that synergism would involve the Runx
iV'
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element located 30 bp upstream of the C/EBP site. Our transient transfection studies of
the OC promoter with mutated elements indicate a role for the C/EBP element in
;'/F,
mediating synergistic activation with Runx2. However, these studies do not exclude
the contribution of the Runx2 binding site to regulation of OC transcription in
,..?,:
J.t . osteoblasts.
The mechanisms by which C/EBP and Runx factors together result in a
synergistic activation of tissue-specific genes may involve modifications in chromatin
structure. Several studies have shown that the Runx and C/EBP classes of transcription
factors can each form regulatory complexes with proteins that influence chromatin
remodeling. Runx factors facilitate the formation and maintenance of transcriptionally
active chromatin (Javed et aI. , 1999; Lutterbach et aI. , 1998; Lian et aI. , 2001) and are
known to interact with co-regulatory proteins possessing histone acetyltransferase
(Kitabayashi et aI. , 1998) or histone deacetylase activity (Lutterbach et aI. , 1998) (Chen
et aI. , 1999). Recent studies from our laboratories indicate that Runx factors regulate
tissue-specific and vitamin D mediated gene expression of osteoca1cin by modifying
chromatin organization (Javed et aI. , 1999). More importantly, C/EBP has recently
been shown to recruit the SWI/SNF complex to modify chromatin and regulate
transcription of myeloid genes (Kowenz-Leutz and Leutz , 1999). Numerous studies
have established that chromatin remodeling and modifications in nucleosomal
organization are necessary for bone specific activation of the osteoca1cin gene (Javed et
aI. , 1999; Montecino et aI. , 1996b; Montecino et aI. , 1999a; Montecino et aI. , 1999b).
Hence , C/EBP-dependent Runx synergism during development of the osteoblast
122
phenotype may result from temporal modifications in the chromatin-related interactions
among C/EBP, Runx , SWI/SNF and/or other components of the nuclear architecture.
In summary, the data presented here address the mechanisms critical for the
robust activation of the osteoca1cin gene during osteoblast differentiation. Our studies
indicate that these mechanisms require a C/EBP response element and synergism of
C/EBP and Runx factors that may be facilitated by their regulated levels of expression
in mature osteoblasts. The concept that lineage specific gene expression depends on
the combination of factors, rather than being controlled by a single master regulator, is
reinforced by these studies.
123
:i:i: :i:!: :i:i: :i:i:
:+:!: :;:!:
:-K
:;:
:i:i: :i:i: :i: )!KK :i:i:
~~~
:i:i: :i:i:i: :i:i:i:i: :i:i:ijg :i:+:i:
'i;,
, ,
tjetl idl Distussfol1
111
:+:i: :.:i:i: :i:i: :i:i: JiK :i:i: :i: :i:i: )iK :i:i:
:!-:
:i:i: )iKK :j:i: : !-:i:i:i:i: K !-:Ki:i:i:-!-:!-:i:i:i:i: :!-:i:i:i:i:
:!-:
:+:i:i: X!-:i:+:i:iji !-:i:i:i:i
GENERAL DISCUSSION
The regulation of gene expression in eukaryotes is highly complex and often
oCCUrs through the coordinated action of multiple transcription factors. Combinatorial
regulation ' of transcription has several advantages , including the control of gene
expression in response to a variety of signals and the usage of a limited number of
transcription factors to create many combinations of regulatory complexes whose
activities are modulated by diverse sets of conditions. This model implies that
ultimately the arrangement of cis-regulatory sequences in the promoter of a gene wil
determine the type of signals to which it wil respond (Pilpel et aI., 2001; Yuh et aI.
1998).
The osteocalcin (OC) gene serves as a paradigm to study tissue specific as well
as hormone induced gene expression. Both transcriptional activity and mRNA levels of
the OC gene are undetectable in early osteoprogenitors and detected at extremely low
levels in postproliferative osteoblasts , but with the onset of osteoblast differentiation
osteocalcin expression is induced , reaching its peak in the mineralizing osteoblast
(Bellows et aI. , 1986; Owen et al. , 1990a). The studies presented in this thesis have
provided novel insight into regulatory mechanisms that contribute to OC expression. In
paricular, we demonstrate that Runx2 is essential for both maximal transcriptional
activity and for the chromatin remodeling that occurs when the OC promoter is
activated. Our results also showed that binding of vitamin D receptor (VDR) is
required to achieve a tight regulation of the OC expression and to complete the
chromatin remodeling of the proximal promoter region during the process of OC
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transcriptional activation. Futhermore
, by sequence analysis of the proximal 
promoter sequence we found a consensus element for the C/EBP family of transcription
factors in close proximity to the Runx binding motif. Northern blot analysis showed
that during differentiation of the primary osteoblast two members of this family: C/EBP
and C/EBP b are being expressed. Finally, we demonstrate that Runx2 and C/EBP
or b act synergistically to enhance DC transcription and this synergism is mediated
through the C/EBP element in the DC promoter.
Runx2 is considered a master gene for bone development. While Runx2
binding to the DC promoter is most probably the signal of cell type specificity for the
expression of binding of C/EBP wil maximize the levels DC in mature
osteoblasts. This combined action for maximal activation of DC is indeed supported by
our demonstration of functional synergism exhibited by C/EBP and Runx 2
transcription factors on the DC promoter. Interestingly, expression of both C/EBP
and osteocalcin are upregulated by vitamin D, a positive modulator of bone formation.
This could well be seen as a concerted effort where an additional signal , the presence of
a steroid hormone , not only enhances osteocalcin expression by directly binding to its
promoter, but it also increases the expression of the positive regulators involved in 
transcription. Given these observations higher basal activity of the VDRE mutant 
promoter (mSHE) is somewhat surprising. However, it is important to note that the
mSHE promoter has only lost the signal for hormonal responsiveness but signaling
from other queues is intact. Therefore, the VDRE mutation transform the arrangement
of the cis-regulatory signals at the DC promoter, from one design to respond to the
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presence of steroid hormones to an arangement that only specify the expression of this
promoter in bone cells.
Because eukaryotic DNA is packaged with histones to form nucleosomes, the
accessibility of transcription factors to their binding sites is limited. Therefore
transcription factors must have the capacity to bind their respective DNA elements even
when they are organized into nucleosomes , or alternatively the DNA must be made
accessible by remodeling of the chromatin. Indeed , examples for both types of
transcriptions factors have been identified (Ostlund Farrants etaI. , 1997; Wechsleret
aI. , 1994). The biological significance of this functional division between factors is
best seen on the induction of the MMTV gene (Di Croce et aI. , 1999; Fletcher et aI.
2000). The promoter of this gene contains five binding sites for glucocorticoid receptor
(GR) and two for the nuclear factor 1 (NFl); GR can bind its cognate element in a
nucleosome , while NFl cannot. Consequently, it has been shown that when the
promoter is packed into nucleosomes , GR is able to bind at least two of these five sites.
Once GR is bound to the promoter, it recruits chromatin-modifying activities that
increase DNA accessibility and facilitate the binding of NFl (Cordingley et al. , 1987;
Archer et aI. , 1991; Pina et aI. , 1990).
Previously, it has been shown that in proliferating osteoblasts the OC promoter
is uniformly packaged in nucleosomes and no nuclease hypersensitivity is detected. In
contrast, when osteoca1cin gene expression is up-regulated postproliferatively and
vitamin D enhancement of transcription occurs , two DNase I hypersensitive sites are
detected , designated as the distal site (-600 to -400) and the proximal site (- 170 to -70)
(Montecino et al. , 1996b; Montecino et al. , 1994b). This demonstrates that the
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transition of the OC gene from transcriptionally inactive to active is accompanied by
changes in chromatin structure of the gene promoter. The studies in this thesis
demonstrate that a key player in OC chromatin remodeling is Runx2; in fact, mutation
of Runx binding sites results in a complete loss of DNase I hypersensitivity and a
reduced accessibility to restriction enzymes (Fig 3. , 4.6C). However, no
significant alteration in basal histone acetylation is observed (Fig. 4.7). These results
suggest that chromatin remodeling at the OC locus is a step-wise process, where some
ofthe steps involved (e. , DNase I hypersensitivity) require binding of Runx2 while
others (histone acetylation) do not. These results also suggest that the generation of
hypersensitive sites most probably results from the action of ATP-dependent chromatin
remodeling factors or histone modifying complexes other than histone
acetyltransferases and that histone acetylation of the OC promoter, although is not
sufficient to support full transcriptional activation of the OC gene , it most probably
required for the binding of transcription factors and/or chromatin remodeling
complexes that wil complete the OC activation process.
VDRE mutation (mSHE) did not affect basal DNase I hypersensitivity;
however, restriction enzyme accessibility of the proximal promoter region was
significantly reduced. This observation is consistent with the ability of VDR to interact
with and recruit components of the basal transcription machinery as well as
coregulators that act on chromatin (MacDonald et aI. , 1995b; Rachez and Freedman
2000). A striking characteristic of the mSHE promoter is increased H3 acetylation
compared to the wild type promoter. It has been reported that, at least in vitro, histone
acetyltranferases exhibit substrate specificity. For example, GCN5 and some acetylases
127
associated with the basal transcription machinery preferentially acetylate histone H3
(Roth et aI. , 2001). Therefore, the increased H3 acetylation levels at the mSHE
promoter most probably reflect the recruitment of a different histone acetylase complex
, alternatively, it may be the result of the acetylase activity associated with the RNA
polymerase complexes that are present at very high levels at this promoter (Fig 4.7).
Vitamin D enhanced activation of the wild type OC promoter is mediated by
histone acetylation (Fig. 4.7, (Shen et aI. , 2002)). Our results demonstrated that this
event is accompanied by increased restriction enzyme accessibility for some of the
enzymes tested (Fig. 4.6A). However, consistent with the lack of vitamin D,
responsiveness of the mutant promoters (mSHE and mAC), no significant changes
either in restriction enzyme accessibility or histone acetylation were observed. These
results suggest that binding of VDR results in the recruitment of additional histone
acetyltransferase complex to the OC promoter.
The sequence of events associated with gene activation has been studied in
several genes; for example , in the cell cycle and developmentally regulated yeast gene
HO the first step in its activation is the binding of the transcription factor Swi5. This
binding is required for the association of the SWI/SNF complex , which in turn is
required for the recruitment of SAGA a histone acetylase complex. Finally the
transcription factor SBF binds to the promoter, but this happens only after both
chromatin-modifying activities have been recruited to the HO promoter. This linear
pathway of ordered recruitment (Swi5 , SWI/SNF, SAGA, SBF) occurs only in mother
cells. In daughter cells, the Ash1 repressor associates with the HO promoter shortly
after Swi5 binding and blocks the recruitment of SWI/SNF and all the subsequent
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events (Cosma et al. , 1999). In contrast, for the interferon B (IF B) promoter the
histone acetylase GCN 5 is first recruited to the nucleosome-free enhancer region of the
gene. This leads to acetylation of a strategically positioned nucleosome , which masks
the TAT A box. The next step is the binding of CBP-pol IT holoenzyme complex
followed by SWI/SNF recruitment resulting in chromatin remodeling that shifts .the
nucleosorne 36 bp downstream, facilitating TBP binding (Lomvardas and Thanos,
2001). This program of sequential recruitment culminates in the binding of TFIil to
the promoter and the activation of transcription (Agalioti et aI. , 2000). Therefore , it
appears that there is no obligate order for function of A TP-dependent remodelers and
covalent modifiers that is general for all promoters. The precise order seems to depend
upon the nature of the promoter, the complement of transcription factors present, and
the chromatin structure in which the promoter resides. Moreover, it seems that there is
no set order of action for chromatin-modifying complexes and complexes in the general
transcription machinery (Soutoglou and Talianidis , 2002; Agalioti et aI. , 2000).
We can imagine that for the OC gene one of the first steps would be histone
acetylation. Chromatin accessibility data suggest that in the proximal OC promoter
both the Runx and C/EBP binding sites are located in the nucleosomallinker region , it
is possible therefore that Runx and/or C/EBP binding wil be one of the earliest events
in OC activation (Fig. 6. 1). This binding of C/EBP could result in the recruitment of a
histone acetyltransferase activity such as p300, which is known to interact with C/EBP
B (Mink et aI. , 1997), and the subsequent acetylation of the promoter. Runx2 can then
be recruited to its cognate binding sites and bring along others coactivators (SWI/SNF
CBP). This in turn wil nucleate the binding of VDR/R and/or other transcription
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mABC
TF? SWI/SNF
CBP
mSHE
POI
YYl VDRlRXR
RNApol
Wild type OC promoter
Figure 6. 1 Postulated model for Osteocalcin Gene Activation: Runx2 and C/EBP
nucleate the recruitment of transcriptional co-activators and additional transcription
factors that render the OC gene transcriptionally active and responsive to steroid
hormones.TF: Transcription Factor, HAT: Histone Acetyltransferase.
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factors and finally results in the binding of RNA polymerase. According to this
model , C/EBP is a family of transcription factors that are critical for normal cellular
differentiation and metabolic functions in a variety of tissues on the Runx mutant
promoter (mABC) only binding of C/EBP and acetylation of the promoter occurs
before the recruitment of RNA polymerase; therefore , a low transcriptional activity
would be observed (Fig 6. 1). In contrast on the VDRE mutant promoter (mSHE)
sequential recruitment ofC/EBP , p300, Runx and SWIISNF would render the promoter
fully competent for transcription and recruitment of RNA polymerase wil result in a
high transcriptional activity (Fig. 1).
In summary, our results indicate that transcriptional activation of OC gene is a
tightly regulated process that involves the recruitment of multiple transcription factors
and chromatin remodeling complexes. Future studies should aim to identify which
factors are recruited in vivo and in what sequence these factors bind to the OC
promoter.
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